Chosen abstracts of VIIIth Polish SNM Congress by NMR redaction,
73
Abstracts
www.nmr.viamedica.pl
Chosen abstracts of VIIIth Polish SNM Congress
STRONTIUM-89 AND PAMIDRONATE IN COMBINED PALLIATIVE
THERAPY OF OSTEOBLASTIC-OSTEOLYTIC BREAST CANCER
BONE METASTASES
Bączyk M., *Bączyk E., Sowiński J.
Dept. of Nuclear Medicine and *Dept. of Palliative Care
University School of Medical Sciences, Poznan, Poland
Introduction. The cancer bone metastases in 40% of patients with advanced breast
cancer are detected; osteolysis predominates in 70% of cases, but in 30% osteo-
blastic component is observed, that gives the possibility for use of strontium-89.
Aim. The aim of this study was to evaluate the effectivness of connected therapy
using strontium-89 (osteoblastic component) and pamidronate therapy (osteolytic
component) in the group of breast cancer patients with multiple osteoblastic-os-
teolytic (mixed) bone metastases.
Material and methods. 13 patients with breast cancer and multiple bone painful
metastases (2 or more) detected by scintigraphy and by radiogram or CT or MRI
(character of metastases) were included in the study. All patients have been treated
with analgetics (NSAID + opioids). Each patient received 150 MBq of strontium-89
(Metastron, Nycomed-Amersham) combined with intravenous infusion of 60 mg
pamidronate (Aredia, Novartis) and short low-dose steroid therapy. The bisphos-
phonate therapy was repeated every month. For assessment of therapy effective-
ness, pain relief (VAS scale), a reduction in analgesic requirements and motor ac-
tivity (ECOG and Karnofsky scale) were evaluated.  The group of 10 patients treated
with bisphosphonate only in the same time was observed.
Results. During follow-up after 4 weeks and 10 weeks of the end of strontium-89
therapy, we noticed pain relief effects as follows: “good” (VAS<2) in 4 patients,
“moderate” (VAS<5) in 5 patients, “no effects” (VAS>5) in 4 patients. We have
observed that the analgesic requirements decreased to 30% of dose on average.
The motor activity of the points evaluated increased from 3 to 2 in the ECOG scale
and  from 40 to 60 in the Karnofsky scale. No pathological fractures, hypercalcae-
mia and other serious side effects with clinical manifestations were observed. The
results of treatment in the group with strontium 89 and bisphosphonate were better
than in the group treated with bisphosphonates only (40% “good” and “moderate”
response rate, one case of pathological fracture).
Conclusions. We conclude that combined palliative therapy using strontium-89
and bisphosphonates is effective (69% “good” and “moderate” response rate) and
safe for bone pain palliation in patients with multiple osteoblastic-osteolytic bone
metastases from breast cancer; it also improves the quality of life.
GALLIUM SCINTIGRAPHY OR 18F-FDG-PET IMAGING? CLINICAL
EVALUATION IN PATIENTS WITH  POST-TREATMENT LYMPHOMA
W. Cholewinski, H. Erler1, D. Kendler1, C. Decristoforo1, R.Greil2, R. Moncayo1
Dept of Nuclear Medicine, Medical University of Lublin. 1Dept. of Nuclear
Medicine, 2Dept. of Hematology and Oncology. University of Innsbruck. Austria
Introduction: Gallium scan for several years has been one of the best nuclear
medicine diagnostic tools in the evaluation of malignant lymphoma. The aim of this
study was to assess the current clinical value of gallium scintigraphy as compared
to 18FDG-PET technique in patients with malignant lymphoma after therapy.
Material and Methods: Both gallium and PET studies were performed in 16 pa-
tients (5F, 11M, mean age 40±16y) with histologically confirmed malignant lym-
phoma: 8 Hodgkin lymphoma (HL) and 8 high-grade non-HL. In all patients chemo-
therapy was completed within at least 4 weeks before examination. Gallium planar
and SPECT images were obtained 48 h post injection of 185 MBq of 67Ga citrate
using double-head gamma camera (Helix, Elscint). 18F-FDG-PET studies were
performed with a double-head digital gamma camera (ADAC VERTEX), equipped
with molecular coincidence detection, 60 minutes post injection of 148-185 MBq of
18F-deoxyglucose. Mean time interval between Ga and PET study was 17 ± 14
days. The sites with pathological tracer uptake were verified by CT (n=16), MRI
(n=2), US (n=2), >2years follow-up (n=10) and histology (n=6).
Results: Gallium scan showed 17 foci with increased tracer uptake in 13 patients.
11 lesion were found above diaphragm and 6 in abdomen. PET studies revealed
pathologically increased glucose uptake in 11 patients in 28 lesions. 10 lesion were
found in thorax and neck, 18 in abdomen. Using gallium scan 10 patients were
diagnosed properly however in the remaining 6 patients gallium scan showed
1 false negative result and in 5 false positive. With 18F-FDG all patients were diag-
nosed according to the presence of disease (11 true positive and 5 true negative).
PET however showed 4 lesions, which during follow-up turned out to be benign.
Conclusions: Gallium scintigraphy has lower sensitivity and specificity than 18FDG-
PET imaging in post-treatment evaluation of patients with malignant lymphoma,
especially when abdominal lesions are suspected. In centers where 18FDG supply
is possible PET imaging seems to be the method which could replace gallium scan
in the clinical evaluation of malignant lymphoma after therapy.
THE POSSIBILITY OF QUALIFICATION PATIENTS SUSPECTED OF
BONE METASTASES FOR SKELETAL SCINTIGRAPHY ACCORDING
TO CONCENTRATION OF COLLAGEN TURNOVER MARKERS
M. Konieczna, J. Pietrzykowski, K. Chmielowski, E. Dziuk
Nuclear Medicine Center, Central Clinical Hospital Military Medical University
Warsaw, Poland
Introduction Malignant metastases to bones develop frequently in the course
of cancer. Their early detectionand the possibility of monitoring of effectiveness
of treatment intended to improve patient’s quality of life are necessary.Finding of an
adequate parameter which could made it possible would be useful for clinical prac-
tice.
Material and methods The study involve 187 cancer patients. Thej were divided
into three groups according to scintigraohy results: group 0 -with normal scintigram
(n=75), group 1-with single „hot” foci (n=74), group 3 - with multiple „hot” foci
(n=38)
Skeletal scintigraphy was performed with gamma camera Apex SP6 after intrave-
nous injection 925 MBq Tc-99m MDP.
In these patients two markers of  bone fomation were determined: amino- and car-
boxyterminal propeptides of I type procollagen (PINP and PICP)The third one was
the marker of bone resorption and collagen degradation product: carboxyterminal
telopeptide of type I collagen (ICTP).
Results All threemarkers are statistically significant increased only in group 2. Ac-
cording to discrimant anaysis  PINP is best marker for discriminating group 2 from
remaining groups.
ICTP  is characterised by highest sensitivity ( 86% )
ICTP and PINP have highest negative pronostic values ( 94 and 92% respectively)
Conclusion PINP is best correlated with scintigraphic result.
PINP and ICTP concentration within reference range may allow abandoning unnec-
essary bone scintigraphy during follow up of dissease.
Markers of collagen turnover alone can not be used for diagnosing  of bone me-
tastases
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THE VALUE OF THE LEFT VENTRICULAR EJECTION FRACTION
ASSESSED BY GATED SPECT PERFUSION SCINTIGRAPHY.
CORRELATION WITH CONTRAST VENTRICULOGRAPHY
M. Kobylecka1, J. Kunikowska1, A. Rak2, L. Królicki1, G. Opolski2
1. Nuclear Medicine Department, Warsaw Medical University
2. Klinik of Kardiology and Internal Medicine Warsaw Mecical University
Background: LVEF is one of the most powerful predictors of prognosis in the cor-
onary artery disease (CAD).  There are several techniques providing the ejection
fraction information used in clinical practice. However the concordance between
them is various in different medical centers.
Aim: Aim of this study was the comparison between Gated 99mTc-MIBI SPECT
LVEF and LVEF obtained from contrast ventriculography in our hospital.
Material and Methods: 51 patients with established CAD, reported for coronaro-
gaphy angiography, were included. All patients underwent the contrast ventriculog-
raphy and the MIBI-perfusion study using a standard two days stress/rest MIBI
SPECT protocol with G-SPECT at rest. LVEF was calculated from G-SPECT resting
perfusion images using the commercial software (QGS-SPECT). A standard tech-
nique was used for EF calculation during contrast ventriculography. The linear re-
gression function for both GSPECT and CV LVEF values was calculated.
Results: LVEF obtained from G-SPECT ranged from 26 to 70% with a mean value
54 (SD 10.6). EF calculated from contrast ventriculography ranged from 50 to 93%
with a mean value 73 (SD 11,6). The differences between G-SPECT EF and CV
LVEF were significant (p<0,05). The correlation coefficient calculated for EF be-
tween both modalities was 0.81.
Conclusions:
1. G-SPECT tends to underestimate LVEF compared to contrast ventriculography.
The difference between both values is statistically significant.
2. The approximate value of the GSPECT LVEF is 0.76 x CV LVEF.
3. It is important to use only one technique for LVEF measurement for patients
follow up studies. However if comparison of various modalities LVEF data is
necessary, the calculated parameter should be used.
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DEVELOPMENT OF A KIT FORMULATION FOR PREPARATION
OF 99MTC-EDDA/HYNIC-TOC
C. Decristoforo1, R. Mikolajczak2, B. Gorska2, A. Markiewicz2, E. Guggenberg1
1University Clinic for Nuclear Medicine, A-6020 Innsbruck, Austria
2Radioisotope Centre POLATOM, 05-400 Otwock - Swierk
Introduction: Clinical studies have shown that 99mTc-EDDA/HYNIC-TOC has prom-
ising properties as a possible replacement of 111In-DTPA-Octreotide for Somatosta-
tin receptor scintigraphy. Direct 99mTc-labelling of HYNIC-TOC with EDDA as coli-
gand results in low and varying labelling yields. The aim of this project was to estab-
lish a formulation suitable for kit formulation based on a Tricine coligand-exchange
reaction allowing quantitative labelling for routine clinical use.
Materials and methods: Parameters such as EDDA concentration, temperature,
pH and 99mTc-activity were tested in a wet formulation. Radiochemical purity was
determined using RP-gradient HPLC and TLC. Peptide integrity was tested in radi-
oligand binding assays. Freeze drying of varios formulations was performed using
a CHRIST alpha freeze dryer.
Results: Using the Tricine-coligand exchange labelling reaction with 1000MBq 99mTc,
20µg HYNIC-TOC at pH6.5, 5mg/ml EDDA, 100° 10min reaction time radiochemi-
cal yields of 95,9%±1,9 (n=5) were obtained with retained receptor binding of the
peptide. For freeze drying modifications of the wet formulation concerning additives
and pH had to be made to grant radiochemical purity and stability.
Two freeze dried formulations resulted in suitable clinical quality. Different batches
at different scale were prepared. Kits with >3 months stability were prepared and
have been used in clinical trials, examples of patient studies will be shown.
Conclusion: A formulation has been developed allowing a routine clinical prepara-
tion of 99m Tc-EDDA/HYNIC-TOC for further clinical evaluation.
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E PERFUSION THE OF THE LOWER LIMBS BY MEANS OF MIBI –
– NORMAL AND PATHOLOGICAL RESLTS ACCORDING OWN DATA
BASE. COMPARISON WITH OTHER NONINVASVE  TPE OF DIANOSTICS
B. Małkowski, Z. Maziarz , R. W. Tryniszewski, A. R. Myślinski, W. Tomaszewski,
Zakład Medycyny Nuklearnej Katedry Diagnostyki WAM Łódź
Lack of normal results of the lower limbs’ perfusion study narrows this type of diag-
nostics to the estimation of present state of perfusion without the conclusions about
the presence and level of perfusion disturbances.
The aim of our study was: 1. Establish normal results of indexes of the lower limb
perfusion, which can be used in our department. 2. Compare normal and patholog-
ical results with other non-invasive diagnostics to assess value of the method. 35
male patients without signs of circulatory disease and 30 with the lower limb’s circu-
latory disturbances were entered into the study. Medium age was 44,4± 3,2 years.
Lower limbs’ perfusion scintygraphy was performed in rest 5 min. after injection of
11,1MBq/kg 99mTc MIBI. The whole body and every part of lower limbs (tights,
calves) acquisition were performed on ELSCINT SP6HR gamma-camera. Symme-
try of the tights and calves perfusion (ST, SC.), indexes of tight (IRTP, ILTP) and
calves (IRCP,ILCP)perfusion for each side of lower limbs were estimated. USG-
Doppler, arm–ancle’s index, blood pressure and laboratory tests were performed
on every patient to exclude circulatory disturbances. Normal results: ST–
102,76%±7,6 SC- 99,27%±9,8 IRTP–10,17±2,5 ILTP–9,9±2 IRCP–10,4±2,3 ILCP–
10,46±2,5. Pathological results were above these values. In the group without cir-
culatory disturbances additional examination did not show any circulatory and lab-
oratory disturbances. In the group with circulatory disturbances of the lower limbs
we found abnormalities in the perfusion studies, USG-Doppler, arm–ancle’s index-
es, cholesterol, and trigliceryd concentration.
Conclusions: 1.The the lower limbs’ perfusion scintygraphy indexes in patients
without circulatory disturbances did not show statistical differences from estimated
mean values.2.Determine normal values enable full diagnosis in patients with the
pathology of the lower limbs’ circulation.
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RADIOPHARMACY
IMAGING CHARACTERISTICS AND DOSIMETRY OF 99MTC-EDDA/HYNIC-
TOC, A PROMISING RADIOPHARMACEUTICAL FOR SOMATOSTATIN RE-
CEPTOR SCINTIGRAPHY AND COMPARISON WITH 111IN-DTPA-OCT-
REOTIDE
W. Cholewinski, C. Decristoforo*, M. Gabriel*, E. Guggenberg*, R. Moncayo*
Dept of Nuclear Medicine Lublin, *University Clinic for Nuclear Medicine,
Innsbruck
Introduction: It has recently been shown that 99mTc-EDDA/HYNIC-TOC (TcTOC)
has promising properties as a possible replacement of 111In-DTPA-Octreotide (In-
OCT) for somatostatin receptor scintigraphy. Its potential advantage lies in a lower
radiation burden to the patient, better availability of the radionuclide and a simplified
imaging protocol compared to 111In-DTPA-Octreotide
Materials and methods: Twenty six patients were studied in comparison with
Octreoscan, after giving informed consent. The patients presented with thyroid ad-
enocarcinomas (n=5), MTC (n=3), GEP-tumours (n=10), carcinoid syndroms with
unknown primary lesions (n=4), paragangliomas (n=2) and pituitary tumor (n=2).
TcTOC was given at a dose of 300-350 MBq and imaging was done at 4h p.i.
including WB scan and SPECT studies. In 10 patients WB scans were performed 15
min, 1h, 4h and 24 h p.i. Final confirmation of suspected lesions was obtained by
correlative inspection of matched CT or MR scans Tracer biodistribution was evalu-
ated using whole body images and conjugated views. Mono- and biexponential
time-activity curves were fitted. These data and physical half-life of 99mTc were
used to calculate the residence times. For calculating self-S values for spherical
tumours, the „Nodule Module” option in the MIRDOSE 3.1 Software was used.
Results: In 7 patients SSTR-scintigraphy was negative with both Tc-TOC and In-
OCT. Matching positive scintigraphic results with both tracers were obtained in 17
out of 19 patients. In-OCT failed to detect two CT-positive thoracic lesions in two
patients with thyroid cancer, whereby these lesions were seen by Tc-TOC. The bio-
distribution and kinetics of 99mTc-EDDA/HYNIC-TOC in the source organs were
used to calculate the residence times. From these values calculated absorbed dos-
es for different organs were: spleen (0,0223 mGy/MBq), kidneys (0,0261 mGy/MBq),
liver (0,0032 mGy/MBq), heart wall (0,0028 mGy/MBq), lungs (0,0063 mGy/MBq).
Conclusion: In this series of patients 99mTc-EDDA-HYNIC-TOC imaging resulted in
equivalent diagnostic information on the somatostatin receptor status, with advan-
tages of a single acquisition, one day protocol and lower radiation dose. The excel-
lent imaging properties resulted in improved diagnosis in 2 of 30 patients when
compared to 111In-DTPA-Octreotide.
75
Abstracts
www.nmr.viamedica.pl
VALUE OF 99MTC-HYNIC-TYR3-OCTREOTIDE IN DIFFERENTIAL
DIAGNOSTICS OF SOLITARY PULMONARY NODULES – PRELIMINARY
COMMUNICATION
A. Płachcińska*, R. Mikołajczak**, A. Markiewicz**, B. Górska**, A. Michalski***,
K. Rzeszutek***, J. Kozak****, E. Młodkowska*, J. Kuśmierek*
* Department of Nuclear Medicine, Medical University of Łódź,
** POLATOM – Świerk, *** Center for Pulmonary Diseases, Łódź,
**** Department of Thoracic Surgery, Copernicus Hospital in Łódż.
Introduction: Overexpression of somatostatin receptors in various malignant tumors
prompted search of somatostatin analogs, which, after radioactive labeling, could be
used in oncological diagnostics. The 99mTc-HYNIC-Tyr3-octreotide is a receptor bound
radiopharmaceutical (RPh) developed in Poland, that now undergoes clinical trials.
The purpose of the present study was the assessment of the RPh’s usefulness for
differential diagnostics of solitary pulmonary nodules (SPN), detected in lung radio-
grams, into malignant and non-malignant tumors.
Material and methods: The study included 25 patients with solitary pulmonary nod-
ules of diameter between 3 ml 7 cm. In all patients a full clinical verification was se-
cured, including bacteriological, cytologic and histologic examinations. In 18 patients
pulmonary cancer was diagnosed (in 16 non-small cell  and in 2 small cell). In 7 re-
maining patients nonmalignant tumors were found (4 tuberculomas, 3 nonspecific
granulomas and 1 nonspecific infection). In all patients receptor scintigraphy was per-
formed, using 99mTc-HYNIC-Tyr3-Octreotide. The activity of the latter, administered i.v.
amounted to ~ 740 Mbq. The scintigraphy was performed applying SPECT proce-
dure 2 hours post-injection, using high resolution collimator and 128x128 images matrix.
Acquisition consisted of 120 projections in full angle of rotation. Tomographic recon-
struction was made applying Metz-filter (3,10). Accumulation of activity was evaluated
in 3 series of cuts: transverse, coronal and sagittal, concentrating on elevation of the
uptake in regions of interest corresponding to localization of the SPN, as seen in radio-
grams. The accumulation of activity in tumors was evaluated in a 4-grade score: 0 -
lack of increased uptake, 1 - slight uptake, 2 - evident uptake and 3 - pronounced
uptake (comparable to the uptake in liver).
Results: In all 18 malignant tumors there was a notable uptake of the RPh: in 15 -
pronounced and in 3 –evident (on the average 2.8,sd-0.4). In 2 of the 7 benign lesions
there was no RPh uptake, in the other 3 -slight, in 1- evident and 1- pronounced accu-
mulation. Mean score in benign lesions was 1.1 (sd-1.1) and was significantly lower
than in malignant tumors (p < 0.001).
Conclusions: 99mTc-HYNIC-Tyr3-octreotide demonstrates a potential usefulness for
differentiating SPN into malignant and benign lesions. Optimal use of the differentiat-
ing properties of the RPh will require application of quantitative assessment of the
uptake and derivation of quantitative criteria that will best serve the diagnostic efficacy
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PRELIMINARY ASSESSMENT OF USEFULNESS OF 99MTC-HYNIC-TYR3-OCTREOTIDE
OF POLISH ORIGIN FOR RECEPTOR SCINTIGRAPHY
E. Młodkowska*, R. Mikołajczak***, A. Markiewicz***, B. Górska***, J. Kunert-Radek**,
J. Kuśmierek*
*   - Dept. of Nucl. Med., **Inst. of Endocrinology, Medical University of Lodz
*** - Radioisotope Center POLATOM Otwock/Swierk
Introduction: A HYNIC-Tyr3-Octreotide conjugate, in form ready for ex promtu labeling with 99mTc,
had been prepared at the Research Development Center POLATOM. Studies performed in vitro and
in vivo on an animal model indicate that the preparation has a high potential to serve for purposes of
receptor scintigraphy in humans. Objective of the study was to assess usefulness of the new ra-
diopharmaceutical (RPh) of Polish origin for scintigraphic detection of neoplasms with enhanced
expression of somatostatin receptors as well as for formulation of indications to somatostatin (Ss)
therapy.
Materials and methods: The study has been made on two groups of patients: A-11 patients in
whom the aim consisted in detection of a possible neoplasm, B -10 patients referred for assess-
ment of somatostatin receptor expression prior to possible therapy with Ss. The activity of the con-
jugate injected varied from 740 to 925 MBq. Scintigraphy (SPECT and/or whole body scan) was
performed  2 hours post administration of the RPh.
Results: The scintigrams obtained were of high quality. As a positive result (+) a focus of  evidently
increased uptake of activity  at the site of a verified lesion was taken. A negative sign (-) indicates
lack of the focal accumulation and +/- a weak uptake, taken as uncertain diagnosis. Summary of
the results in both groups are presented in tables I and II (below).
Table I. Search for possible neoplasm.
Clinical diagnosis Results + Results - Results +/- Overall
Pulmonary cancer 3 0 1 4
Carcinoid 2 0 0 2
Melanoma (skin) 2 1 0 3
Mammary cancer 1 0 0 1
Serotonin secreting tumor 0 0 1 1
Total 8 1 2 11
Table II. Selection of patients for possible sandostatin therapy
Clinical diagn. Results + Results - Results +/- Overall
Hypophyseal tumor 4 0 0 4
Tu. secret. ACTH (nonoper.) 0 1 0 1
Thyroid medullary cancer 0 1 0 1
Sarcoidose (pulm.,eyes) 1 0 0 1
Diabetic retinopathy 2 1 0 3
Total 7 3 0 10
Conclusion: The tested new radiopharmaceutical seems to be potentially useful for detection of
tumors with overexpression of somatostatin receptors. The results suggest also usefulness of the
RPh for rational substantiation of sandostatin therapy in patients with various ailments in whom
density of the somatostatin receptors is uncertain.
DIFFERENCE IN METASTATIC PATTERN OF DISEMINATED CARCIONID
IN PATIENTS WITH SECRETOR AND NON-SECRETOR TUMOURS USING
IN-111 OCTREOTIDE
Jaroslaw B. Ćwikła, John R. Buscombe, Martin E. Caplin, Andrew J.W. Hilson
Department of Nuclear Medicine and NET Clinic, Royal Free Hospital; London,
NW3 2QG
Functional imaging modality is standard technique to assess presence and extent
of disseminated carcinoid.
AIM OF THE STUDY Aim of the study was to assess if there is any difference in
tumour extent detected by radionuclide study in both secretor and non-secretor
carcinoid.
MATERIALS AND METHOD: Overall 79 patients, all with histology confirmed car-
cinoid. Secreting tumours with carcinoid syndrome was present in 30 patients. In-
111 Octreotide study was performed using standard imaging protocol. Each study
was evaluated to presence of tumour extent within liver, bone, chest, lymph node
and  pelvis. Part of the body or organ were assess as follows: no detected lesion,
presence of single lesion, 2<lesions<5 and more then 5 lesions detected.
RESULTS: In non-function tumours 16 patients had foregut carcinoid, 24 patients
midgut, single hindgut, 8 patients had no origin primary. Patients presented secre-
tor carcinoid tumours had 6 foregut origin tumours, 17 midgut tumours, single hind-
gut tumours and 6 had no-origin. In-111 Octreotide radionuclide study was able
detect disease within liver in 65% of patients, there were 29% of patients with multi-
ple liver metastases. Secretor tumours had multiple liver metastases (more than 5
lesions) in 80% of patients, no liver deposits had 10%  of patients. Those patients
with non-secretor tumours had in 29% of cases multiple liver deposits. There were
significant difference between both groups (p<0.01 Mann-Whitney U test). No bone
involvement were detected in 87% patients with secretor tumours and 96% of pa-
tients with non-secretor tumours (p>0.05). Lymph node involvement was detect in
60% of secretor tumours and 35% of non-secretor tumours (p>0.05), but 33% of
secretor tumours had multiple nodes compare to 18% of non-secretor tumours
(p<0.05). Pelvic lesions were In-111 Octreotide positive in 40% in patients with
secretor carcinoid compare to 49% in non-secretor tumours (p>0.05).
CONCLUSION: These results suggest that there is significant difference between
metastatic carcinoid tumour pattern within liver and lymph nodes involvement con-
sider secretor and non-secretor  tumour.
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LYMPHOSCINTIGRAPHIC DETECTION OF SENTINEL NODE IN PATIENTS
WITH CUTANEOUS MELANOMA – OWN EXPERIENCE
E. Młodkowska*, J. Kuśmierek*, A. Berner**, D. Nejc**
* Department of Nuclear Medicine, Medical University of Łódź
** Department of Oncological Surgery, Center of Oncology,
Medical University of Łódź
Introduction: In patients with cutaneous melanoma a sentinel node (SN) for the
tumor may be detected by means of lymphoscintigraphy (LS).
Objective of the study: Optimization and assessment of efficacy of the LS meth-
od for detection of the sentinel node.
Materials and methods: 74 patients (pts) with surgically removed primary lesion
were studied. LS was performed on a day preceding surgical biopsy of the SN. 74
MBq of 99mTc Nanocoll were equally distributed into 4 syringes, which served for
intradermal injections of the sites surrounding the scar, remaining after removal of
the primary melanoma focus. The imaging was started immediately after adminis-
tration of labeled Nanocoll and  appearance of the focus of activity, representing
the SN was noted and localized on skin surface by means of 57Co point source. In
following images penetration of the radiopharmaceutical in lymph nodes of the re-
gional and distal groups was observed, making detection of sometimes remote
sentinel nodes possible.
Results: SN (or several nodes) were identified in all of the 74 pts (100 %). Visualiza-
tion occurred within 2 to 40 (mean 12 + 10) min. post injection. The time to appear-
ance was longer for head, neck and  trunk and shorter for extremities. A SN in only
one regional lymph node group was observed in 57 pts (77%) and in two groups in
17 pts (23 %). The latter finding was noted mainly in cases of localization of the
primary neoplasm on the trunk, in close proximity to the midline of the body. In 36
patients (49%)  2 SN were observed - in nearly half of them in the same regional
lymph node group. In 2 pts 3 SN and in other 2 pts 4 SN (in two groups) were
localized. In 56 patients (76 %) there were no technical difficulties noted in the pro-
cedure; in the remaining 18 (24 %) there was insufficient contrast between count
rate over the SN and the surrounding tissues; in such cases lead shielding was
applied to the injection site, to eliminate the high count rate.
Conclusions: The preoprerative SN lymphoscintigraphy is a safe procedure, in
most cases easy to perform and highly efficacious in visualization of SN(s) in pa-
tients with cutaneous melanoma.
SAMARIUM PLAYS MAJOR ROLE FOR THE PALLIATION OF PAINFUL
BONE METASTASES
Mosa M.
Lacomed Ltd., Area on NRI plc., CZ – 250 68 REZ, Czech Republic,
mosa@lacomed.cz
Abstract: It is know that nearly 50% of patients with breast or prostate cancer will
eventually develop bone metastases. A prominent symptom of these metastases is
pain. Since control of metastatic bone pain is a clinical problem, an effective agent
for palliation of bone metastases has been searched.
Question is that the radiopharmaceuticals containing samarium-153, strontium-89,
rhenium-186, phosphorus-32 are effective, but we do not know which of these is the
most efficacious or the safest. Toxicity includes mild-to-moderate pancytopenia and
an occasional brief flare of pain, and treatment of patients with disseminated intra-
vascular coagulation must be avoided because it may predispose the patient to
severe thrombocytopenia.
Post clinical study by means of Sm-153, Sr-89, Re-186 and P-32 for total 680 pa-
tients we can answer, that the earliest time interval to higher level of platelets after
initial injection, shows samarium-153.
Sm-153 injection is a safe and effective agent that, due to the complex of radioac-
tive samarium and ethylene-diamino-tetarmethylene phosphonic acid (EDTMP) pro-
duced into Czech Republic via LACOMED Ltd., shows also an optimal outstanding
affinity to the bone metastatic lesions. The clearence of the radiopharmaceutical is
very short, the urine excretion is completed within 24 hours after administration. The
elimination of drug is characterized by double-exponential curve with half times
about 5 minutes and 1 hour. Two hours after administration there is only 5% of the
activity applied in the blood.
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THE EFFECTIVNESS OF STRONTIUM 89 IN PALLIATIVE THERAPY
OF PAINFUL PROSTATE CANCER BONE METASTASES
Bączyk M., *Milecki P., **Bączyk E., Czepczyński R., Sowiński J.
Department of Nuclear Medicine, ** Departament of Palliative Care
University School of Medical Sciences, Poznań, Poland
* Great-Poland Cancer Center
Introduction. The cancer bone metastases in 80% of patients with advanced pros-
tate cancer are detected.
Aim. The aim of this study was to evaluate the effectivness of strontium 89 (Metas-
tron) therapy in the group of prostate cancer patients with multiple bone metastas-
es.
Material and methods. The study included 57 patients (aged 53 – 8 ) with prostate
cancer and multiple bone painful metastases (2 or morE) detected by scintigraphy
and by radiogram or CT or MRI - character of metastases (osteoblastic – 47 pa-
tients, osteolytic-osteoblastic – 10 patients). In the all group somatic bone and neu-
ropathic pain was detected. All patients have been treated with analgesic manage-
ment (NSAID or/and opioids). Before strontium 89 therapy 24 out 57 patients have
been performed local irradiation to the back bone as prevention of spinal cord com-
pression. 52 patients received a standard dose 150 MBq of strontium 89, 5 patients
a reduced dose 75 MBq (worse haematological parameters), combined with short
low-dose steroid therapy. For assessment of therapy effectivness; pain relief (VAS
scale), a reduction in analgesic requirements and motor activity (ECOG and Kar-
nofsky scale) were evaluated.
Results. During follow-up after 4 weeks and 10 weeks of the end of strontium 89
therapy we noticed pain relief effects as follows: “good” (VAS<2) in 30 patients (13
with additional radiotherapy), “moderate” (VAS<5) in 20 patients (7 with additional
radiotherapy), “no effects” (VAS>5) in 7 patients (4 with additional radiotherapy).
We have observed that the analgesic requirments decreased to 50% of dose on
average. The motor activity of the points evaluated according to ECOG scale and
Karnofsky scale was much better (p < 0,05). 2 cases of pathological fractures, 6
cases of mild hypercalcaemia and no serious  haematological side effects with
clinical manifestation were observed. The results of treatment in the group with stron-
tium 89 were much better than in the group without therapy (8 patients with pancy-
topenia and osteolysis)
Conclusion. We conclude that palliative therapy using strontium 89  is effective
(88% “good” and “moderate” response rate) and safe for bone pain palliation in
patients with multiple prostate cancer bone metastases; it also improves the quality
of life.
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USEFULNESS OF SERUM TUMOUR MARKERS (CEA, CA-15.3,TPA) MEASURMENTS
IN EVALUATION OF BREAST CANCER NEOADJUVANT CHEMOTHERAPY
A. Kochańska-Dziurowicz1, T. Jankowski2, A. Bijak1, A. Stanjek1, E. Górna2
1Department of Radioisotope Diagnostics and Radiopharmaceuticals Medical, University Silesian;
2Oncological Clinic SPZOZ in Chełm,
Introduction: In most countries of the world, as well as in Poland, breast cancer is
the major oncological issue, as it represents 17% of malignancies in women. Early detection makes
it curable. Physical examination, visual techniques and above all serum tumor markers measure-
ments are the main tools in early diagnosis of breast cancer. The aim of the study was establishing
the usefulness of serum tumor markers(CEA, CA- 15.3, TPA) measurements in evaluation of breast
cancer neoadjuvant chemotherapy in accordance with the CMF regimen.
Material and methods: The study included 30 women aged 30-68 (mean age 51.8) diagnosed
with breast cancer, who were admitted to Oncological Outpatient Ward in Chelm, Poland. Breast
cancer in the second clinical stage was recognized in 18 cases (60%) and 12 (40%) in the third
clinical stage.
Blood samples were taken on the first day and after three courses of chemothera-py using CMF
regimen, and frozen in -20°C. Concentration of markers were evaluated using IRMA method: CA -
15.3 and CEA – CIS and TPA – Byc-Sangtec. The percentage of confirmed positive values prior to
the treatment was 40%, 23.3% and 10% respectively for CA-15.3, TPA and CEA.
We found statistically significant differences( p<0.05) between arytmetic mean concentration in
tumour markers prior to and after neoadjuvant chemotherapy.
Geometric mean with semi-interquartile range of serum concentrations are presented in table.
Clinical stage CEA [ng/ml] CA-15.3 [U/ml] TPA [U/l]
Normal range <4.0 <30 <75
Before treatment n=30 2.29 ± 0.80 49.1 ± 29.3 28.1 ± 25.0
Before treatment with IIo 2.24 ± 0.65 45.3 ± 25.5 21.8 ± 15.2
Before treatment with IIIo 2.38 ± 0.91 55.5 ± 49.0 40.9 ± 60.5
After treatment n=30 1.96 ± 1.10 22.7 ±   7.5 10.6 ± 21.9
After treatment with IIo 1.71 ± 1.10 19.7 ±   5.7   8.2 ± 17.0
After treatment with IIIo 2.43 ± 0.90 28.0 ± 10.0 15.5 ± 25.7
Usage 3 of CMF at women from IIo caused lowering CA-15.3 to physiological concentrations and at
women from IIIo to upper limit norm. Geometric mean TPA concentrations being in range of norm
submissive further to lowering, instead CEA concentrations being in range of norm submissive after
treatment to lowering only at women from IIo.
Conclusion: Obtained results show that in chance of estimation of efficiency of treatment of breast
cancer CMF greatest value diagnostic possesses CA-15.3 marker.
The study was supported by ŚAM grant NN-2-100/01, agreement of Ethical Committee NN-013-
439/99.
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THE COMPARISON OF TC-99M-MIBI SPECT AND GATED SPECT
(GSPECT) IN DIAGNOSIS OF CORONARY ARTERY DISEASE
1J. Pietrzykowski1, M. Dziuk2, M. Zachorski3
1Centre of  Nuclear Medicine , 2The Institute of Internal Medicine Department of
Cardiology,3 Department Cardiology of Observation Central Clinical Hospital
Military School of Medicine Warsaw
Introduction: A standard SPECT acquisition makes possible a spatial image of
myocardium perfusion defect at stress and rest as well as quantification of their
reversibility. GSPECT (gated SPECT) defines simultaneously perfusion and func-
tion: thickening, myocardial motion, ejection fraction value end-systolic volume and
end-diastolic volume. Information on both of perfusion and function of myocardium
(GSPECT) permit  to determine the myocardial status.
Aim of study: SPECT and gated SPECT comparison and estimation of incremen-
tal GSPECT parameters value in recognition of myocardium function and perfusion
defects.
Material and methodology: Studies were performed in 143 patients with suspect-
ed or known coronary artery disease.  Studies were performed in 2-day protocol:
exercise stress on first day, rest after three days. We analyzed the isotope uptake in
myocardium, ejection fraction, end-systolic volume and end-diastolic volume aim-
ing to recognize a coronary disease.
Perfusion scintigraphy was reported positive if the uptake was decreased in stress
with improvement at rest. Perfusion scintigraphy was negative if no perfusion de-
fects were found in stress and rest study, permanent perfusion defects in both of
tests, proper perfusion in stress study and its decrease at rest.
Results: The average difference of ejection fraction (DEF) in studied patients with
negative(-) and positive(+) scintigraphy was smaller than 1%. The change of end-
systolic volume (ESV) in patients with positive scintigraphy reached a statistical
significance of trend. The was no correlation found between perfusion reversibility
and change of end diastolic volume.
Conclusions: (DEF) does not show to be helpful to estimate the result of treadmill
exercise scintigraphy in the study group. There are no physiological changes in end
systolic(ESV) and end diastolic(EDV) volumes in patients with positive scintigraphy.
The changes of volume (DESV) can be helpful in ischaemia diagnosis.
ESTIMATION OF USEFULNESS OF MONITORING TPA CONCENTRATIONS IN THE
EFFECTIVENESS OF SURGICAL TREATMENT OF URINARY BLADDER CANCER
A. Kochańska-Dziurowicz1, M. Mielniczuk2, A. Bijak1, M. Jamroz1, M. Gizdoń1
1 Department of Radioisotope Diagnostics and Radiopharmaceuticals Medical University
of Silesia, 2 Department Urological of District Specialistic Hospital in Bytom,
Introduction. Urinary bladder cancer takes the third place in all cancer tumors. Each year in Poland
4000 new cases of this disease are diagnosed. Incidences of this disease are most frequent in men
above 60.
Björklund discovered tissue antigen polipeptid (TPA) in cancer tissue. At present it is considered
that it is not proliferation but apoptosis marker. In the cancer cells TPA is found most abundantly on
the surface of tumors, in proliferation places, that is in groups of cells attacking surrounding tissues.
TPA penetrates to blood serum and its concentration exceeds 85 U/l.
The aim of this work was to answer the question whether TPA determination in patients after elec-
troresection of urinary bladder cancer can be used to establish the probability of tumor reemission.
Material and methods: The research included 98 patients, all of whom had under-taken electrore-
section of urinary bladder tumor (TURT - transurethtral resection of tumor), which enabled its remov-
al, and then estimation of malignancy and progresssion stage according to international TNM scale.
The mean age was 62.7. All patients had blood samples taken to determine TPA, and then under-
went routine cystoscopy examination. TPA was determined using IRMA method with Byk-Sangtec
kit.
Results. All patients were divided according to cystoscopy results into two groups: patients with
tumor reemission (60 patients; mean age 64 ± 10) - group 1 and patients without reemission (38
patients; mean age 61.3 ± 11) - group 2. The geometric mean concentration of TPA in the first
group was 30.2 U/l, and in the second group 26.2 U/l (p>0.1).
           TPA Geometric mean [U/l]
T1 T1/2 T2 T2/3 T3 T3/4
Withreemission 30.4 10.2 23.2 31.5 59.8 161.6
(n = 60) (21.7%) (6.6%) (41.6%) (11.7%) (13.3%) (5%)
Without reemission 25.5 32.51 24.7 17.5 43.9 —
(n = 38)  (31.5%) (0.5%)  (50%) (2.6%) (5.3%) (0%)
In brackets the percentage of patients according to progression stage.
Taking the TPA threshold point 85 U/l as normal true-positive results were 16.3% and true-negative
were 31.6%, false-positive results were 7.1% and false-negative were 44.9%.
The ROC curves with calculated area under them are the measurement of diagno-stic estimation of
TPA concentrations in specificity and sensitivity categories. For examined group the calculated
P was 0.45. If P value is under 0.5 it is considered that test should not to be used in diagnosing
reemission of bladder cancer.
Conclusions. Determination of TPA concentrations in patients after electroresection cannot the
base for estimation of cancer reemission or recovery.
15
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P-CARDIOLOGY
99M-TC SESTAMIBI MYOCARDIAL SPECT AT REST AND AFTER
DIPYRIDAMOLE IN PATIENTS WITH CARDIAC SYNDROME X
R. Czepczyński, D. Rogacka*, I. Smolarek, R. Oleksa, H. Wysocki*, J. Sowiński
Dept. of Endocrinology and Metabolism, *Dept. of Intensive Cardiological Care,
Univ. School of Medical Sciences, Poznań
Introduction. Patients with anginal chest pain, a positive result of exercise test and
normal arteries in coronary angiography are classified as cardiac syndrome X. Aim
of the study was to analyse the results of SPECT in patients with cardiac syndrome
X and to define the role of myocardial perfusion SPECT in the diagnosis of syn-
drome X.
Material and methods. All patients qualified to the study fulfilled the criteria of 
syndrome X. The group consisted of 68 patients - 48 women(63,2%) and 25 men
(36,7%) aged from 32 to 60 years (median 45 years). 99m-Tc-sestamibi SPECT at
rest and after dipyridamole infusion (0,56 mg/kg body weight) was performed ac-
cording to the two-days protocol. The perfusion of each 9 segment of left ventricle
was assessed using a 4-points scoring system (from 0 to 3), where 0 meant ab-
sence of radio-tracer uptake and 3 stood for normal uptake. The summed scores of
all segments at rest (Ss) and after dipyridamole (Sd) was analysed statistically.
Results. Some significant ECG abnormalities during dipyridamole infusion were
detected in 24 patients (35,3%). Ss was from 16 to 27 (average 22+/-2,7) and Sd
was from 16 to 27 (average 22,4+/-2,5). There was no significant difference be-
tween Ss and Sd. The individual evaluation, however, showed an impairment of
myocardial perfusion by 1-6 points after dipyridamole infusion (Sd<Ss) in 26 pa-
tients (38,2%), an improvement of perfusion by 1-7 points in 28 patients (41,2%)
and no change of perfusion in 14 patients (Sd=Ss). In 6 patients, impairment of
perfusion in some segments and improvement in other segments at the same time
was found. SPECT results were independent of patients’ age. The improvement of
myocardial perfusion was more frequent in men (12/25 - 48%) than in women (16/
43 - 37%).
Conclusions. 99m-Tc-sestamibi myocardial SPECT demonstrates different pat-
terns of myocardial perfusion disturbances (decrease, increase or no change of
perfusion after dipyridamole) in patients with cardiac syndrome X. Thus, in some
patients with this syndrome, in whom no perfusion impairment after dipyridamole is
found, coronary angiography can be avoided.
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DOES QUANTITATION OF MYOCARDIAL PERFUSION SPECT STUDY
DIFFER WHILE IMAGE RECONSTRUCTION IS CARRIED OUT USING
ITERATION ALGORITHM INSTEAD OF FILTERED BACKPROJECTION?
Krzysztof Kędziora, Piotr Lass
Department of Nuclear Medicine, Medical University, Gdańsk, Poland
BACKGROUND: The purpose of this study was to compare performance of two
reconstruction algorithms: conventional filtered backprojection (FBP) and an itera-
tive algorithm - ITW in quantitative analysis of myocardial perfusion SPECT studies.
The defect size and defect severity were assessed on 99mTc-MIBI images recon-
structed using both methods and estimation of sensitivity in the detection of perfu-
sion deficits and myocardial viability were performed as well.
METHODS AND RESULTS: The study group comprised 43 patients (38 men and
5 women) at the age of 40-73 years (mean 59 years). Heart perfusion scintigraphy
has been performed following an injection of 22 to 25 mCi 99mTc-MIBI for exercise
and rest myocardial perfusion study. Images were reconstructed using FBP and
ITW algorithms. Defect size (DS) was quantified by a threshold program and CEqual
programme. Defect severity (nadir) was calculated as the ratio of minimal/maxi-
mum counts from bull’s eye polar map. Coronary arteriography has been performed
in all patients
RESULTS: Defect size calculated by threshold method on resting images did not
differ between reconstruction methods (p=0,61 for cut-off 50% and p=0,24 for cut-
off 60%);  defect severity was higher on images reconstructed with ITW (CI0,95 =
2,4% ÷ 5,2% of maximal counts).
CONCLUSIONS: Sensitivity for detection of  heart perfusion defects and estima-
tion of myocardial viability were similar on images reconstructed by both algorithms.
APPLICATION OF RADIOGUIDED OCCULT LESION LOCALISATION
METHOD IN SUBCLINICAL RECURRENCIES OF DIFFERENTIATED
THYROID CANCER
M. Turska1, B. Mąka1, A. Sacher1, J. Krajewska2
1 Clinic of Oncological Surgery, Center of Oncology, Maria Sklodowska-Curie
Memorial Institute, Gliwice Branch, 2 Dept. of Nuclear Medicine and Endocrine
Oncology Maria Sklodowska-Curie Memorial Institute, Gliwice Branch.
Clinically occult loco-regional recurrences in thyroid cancer patients can be operat-
ed by applying ROLL method (Radioguided Occult Lesion Localisation). In this
method we use 99mTc - albumin (ALBU-RES, 100 µCi in 0,1 ml) into cytologically
diagnosed lesions using ultrasound-guided technique. Afterwards, we are able to
localize precisely these small tumors by means of intraoperative gamma-rays de-
tector.
Our material consists of eight thyroid cancer patients who have been operated many
times and treated by iodine 131I. Six of them had local recurrence, in two – neck
lymph node metastases were diagnosed. We were able to localize all the lesions (5
to 20 mm in diameter) described in ultrasound examination. All of them where patho-
logically proved, afterwards.
Conclusions: Application of ROLL method in subclinical recurrence of differentiat-
ed thyroid cancer allows to:
— shrink the operation field
— shorten the operation time
— minimize the frequency of complications
EFFECT OF LITHIUM CARBONATE ON 131-I UPTAKE IN THE THYROID
GLAND.
Płazińska M.T., Królicki L., Jędrzejowski M.
Departrment of Nuclear Medicine, Medical School of Warsaw.
The iodine kinetic in thyroid tissue is significantly affected by lithium salts. They
block the release of organic iodine from the thyroid gland. This effect suggests that
lithium may be useful as an adjunct to radioiodine therapy in thyrotoxicosis.
The aim of this work was to evaluate the influence of lithium carbonate pretreatment
in the group of hyperthyroid patients with low and normal iodine uptake. We evalu-
ated the iodide uptake before and after lithium carbonate intake in 10 patients with
RAILI<30% and RAIIJ>40%. Both groups were discriminated according of disease,
age, sex and duration of disease as a possible factors influencing the results. Kinet-
ic examinations of iodine uptake were repeated after lithium carbonate was includ-
ed in the dose of O.5g per day. The retention of iodine in the first group at the 6 and
24 hours amounted 13 +/- 4%, and 25 +/- 6%, respectively and in the second group
32 +/- 5% and 51 +/- 9%, respectively.
No effect of lithium carbonate on the 131-I uptake was noted in all patients with
baseline RAIU>40%. The uptake of iodine after 6 and 24 hours were
34 +/- 4% and 55+/-6%, respectively. Despite the lack of effect on the radioiodine
uptake a significant prolongation of the biological and effective half live time were
observed. The biological half live time increased from 24 to 240 days and effective
half live time increased from 6 to the 7.8 days (p< 0.005).
A significant increase of iodine retention was noted in patients with baseline
RAIU<30%. During lithium carbonate treatment T6 increased to the 21+/-5%
(p< 0.01 ) and T24 to the 38 +/-7% (p< 0.001 ). The biological half live time in this
group increased from 5.8 to 267 days (p< 0.001) and effective half live time amounted
7.8 days (p< 0.001 ).
The results indicate that the response of iodine uptake on the lithium carbonate
depends on the baseline RAILJ but the response on the biological and effective half
live times are uniform.
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THE COMPARISON OF DUAL-PHASE TC-99M MIBI SCINTIGRAPHY VER-
SUS TC-99M/TC-99M MIBI SUBTRACTION SCINTIGRAPHY IN PATIENTS
WITH PRIMARY HYPERPARATHYROIDISM
M. Kobylecka, J. Miśkiewicz, M. Jędrzejowski, L. Królicki
Nuclear Medicine Department, Warsaw Medical University
Background: Technetium-99m MIBI scintigraphy is one of the basic modalities of
preoperative diagnosis of primary hyperparathyroidism. The preoperative parathy-
roid scintigraphy is routinely performed by using 201Tl/99mTc subtraction tech-
nique or dual-phase 99mTc MIBI scintigraphy. Dual-phase 99mTc MIBI scintigra-
phy is based on the delayed washout of MIBI from parathyroid tissue compared to
thyroid tissue. In patients with concomitant goitre or focal thyroid lesions dual-phase
scan results may be not evident. In this cases, additionally, subtraction MIBI scans
are performed.
Aim: The aim of this study was to compare the diagnostic value of dual-phase
99mTc MIBI versus 99mTc/99mTc MIBI subtraction scintigraphy in patients with
primary hyperparathyroidism from endemic thyroid goitre area.
Material and Methods: Scintigraphic scans of 67 patients with primary hyperpar-
athyroidism confirmed by laboratory tests were analysed. In 40 patients (59%) the
goitre or focal thyroid lesions were observed. In all cases the dual-phase MIBI scin-
tigraphy was performed. Additionally, in 27 patients, the 99mTc/99mTc subtraction
scintigraphy was acquired. At least one focus of abnormal MIBI accumulation was
considered positive.
Results:  34/67 (51%) focal pathological lesions of increased MIBI accumulation
were observed. In this group 16/40 (40%) patients had concomitant goitre or focal
thyroid lesions and 18/27(66%) patients had no pathological thyroid changes. The
subtraction scans showed additionally 17 pathological changes that were not visu-
alised in dual-phase scans. In this group 12 patients had concomitant goitre or
focal thyroid lesions and 5 patients had no pathological thyroid changes.
Conclusions:
1. Sensitivity of dual-phase MIBI scintigraphy and 99mTc/99mTc-MIBI subtraction
scans in patients with primary hyperparathyroidism without pathological thyroid
changes is comparable.
2. Subtraction scans in comparison with dual-phase scintigraphy allows to visual-
ise more pathological parathyroid glands, especially in patients with goitre or
focal thyroid lesions.
THE USEFULNESS OF 99M-TC- MIBI SCINTIGRAPHY IN THE DIAGNOSIS
AND LOCALIZATION OF HYPERFUNCTIONING PARATHYROID GLANDS,
IN SECONDARY AND TERTIARY HYPERPARATHYRODISM
Kobylecka M1, Jędrzejowski M1, Chudziński W2 , Królicki L1
1Nuclear Medicine Department, Warsaw Medical University
2Klinik of General, Vascular and Transplant Surgery Warsaw Mecical University
Background: Technetium-99m MIBI scintigraphy is useful in the diagnosis of pri-
mary hyperparathyroidism.
Aim: The aim of the work was to study the diagnostic value of Tc-99m MIBI scintig-
raphy to localize anomalous parathyroid glands in patients with secondary and ter-
tiary hyperparathyroid disease.
Material and Methods: We studied 73 patients with secondary and tertiary hyper-
parathyroid disease. Each patient was injected with 555 to 740 MBq (15 to 20 mCi)
Tc-99m MIBI. The radionuclide images were acquired 20 and 120 minutes after
injection using a low-energy, all-purpose, parallel-hole collimator. In 48 cases pertech-
netate thyroid scintigraphy was obtained prior to MIBI scintigraphy, subsequently
99mTc/99mTc-MIBI subtraction was performed. The pathological focal uptake in
the neck /mediastinum region was considered positive.
Results: At least one focus of abnormal MIBI accumulation in dual phase MIBI
scintigraphy as found in 16 cases (22%). An ectopic gland was found in four cases.
The subtraction showed focal uptake with no retention in 14 cases. The overall MIBI
sensitivity was 41%. After parathyroidectomy the abnormal gland was found in all
operated cases.
Conclusions:
1. The sensitivity of 99mTc- MIBI scintigraphy in secondary and tertiary hyperpar-
athyroidism is low, but comparable to the reported results at various institutions.
2. The subtraction may improve the results of MIBI scintigraphy, when routinely
used.
3. The reason of the difference between dual phase and subtraction MIBI scintigra-
phy might be the high rate of thyroid goiter and focal thyroid lesion and presence
of parathyroids with atypical washout.
CEREBRAL BLOOD FLOW SPECT MAY BE HELPFUL IN ESTABLISHING
THE DIAGNOSIS OF PROGRESSIVE SUPRANUCLEAR PALSY AND
CORTICOBASAL DEGENERATION
Jaroslaw Sławek, Piotr Lass, Mirosława Derejko, Mirosława Dubaniewicz,
Justyna Scheffler
Department of Neurology and Outpatient Department of  Extrapyramidal
Disorders, St. Adalbert Hospital, Gdańsk, Poland
Department of Nuclear Medicine,  Department of Radiology, Medical University,
Gdańsk, Poland
BACKGROUND: We present 5 cases, which illustrate the usefulness of neuroim-
aging studies in atypical forms of parkinsonism. Progressive Supranuclear Palsy
(PSP) and Corticobasal Degeneration (CBD) are rare neurodegenerative progres-
sive disorders of central nervous system of unknown cause. Those diseases for
similarity to Idiopathic Parkinson’s Diseases (IPD) but more  differentiated clinical
symptoms and signs are classified in a group of s.c. parkinsonism-plus. The clini-
cal accuracy in this diagnosis is not very high even in the centres specialised  in
movement disorders, with usual initial diagnosis of IPD. Functional imaging can be
helpful in diagnosing of PSP and CBD, as rCBF SPECT changes may precede CT/
MRI changes.
METHODS: We present the results of cerebral blood flow (CBF) SPECT scanning
in 2 patients with PSP and 2 patients with CBD. This was performed using a triple-
head gammacamera and 99mTc-HMPAO
RESULTS: In PSP patients a diffuse frontal perfusion deficit was seen, eventually
with striatal and occipital hypoperfusion. CT/MRI was either normal or showed
a diffuse cortical-subcortical atrophy. In CBD patients left fronto-parieto-temporal
cortex as well a striatal hypoperfusion was showed. CT scanning was normal in one
case either normal or showed an asymmetrical temporo-parietal atrophy. In 2 pa-
tients rCBF SPECT changes preceded CT/MRI changes.
CONCLUSIONS: The pattern of diffuse frontal perfusions deficit in PSP and asym-
metrical, subcortical hypoperfusion contralateral to initially unilateral symptoms of
CBD cortico- may be helpful in establishing the correct diagnosis. It may enable
early diagnosis and early medication slowing down the progression of disease.
rCBF SPECT scanning is also less expensive than one with the use of specific
ligands, although also less specific.
REGIONAL CEREBRAL BLOOD FLOW IN POSTMENOPAUSAL WOMEN
ON HORMONAL REPLACEMENT THERAPY
R. Junik*, R. Słopień, **J. Sowiński, A. Warenik-Szymankiewicz
*Department of Endocrinology and Diabetology of L. Rydygier Medical University,
Bydgoszcz, **Department of Endocrinology and Metabolic Diseases,
Department of Gynecological Endocrinology, K. Marcinkowski University of
Medical Sciences, Poznań
The aim of this study was evaluation of the influence of hormonal replacement
therapy (HRT) on the regional cerebral blood flow in postmenopausal women.
Material and methods: Twenty postmenopausal women were studied, mean age
48,7 ± 4,9 years. The study was repeated after 1 year of HRT. The severity of cli-
macteric syndrome was measured with the use of  Kupperman index and serum
FSH and 17b-estradiol levels.rCBF was measured using SPECT. Tracer’s uptake
was estimated in cerebellar, thalamic, and ventricular slices. Brain SPECT was
repeated.in 10 women with an impairment in the  rCBF at the beginning of the study.
Results: Before HRT mean value of the Kupperman index in the study group was
29,8 ± 7,1 points and after one year of HRT the value of the index was 13,2 ± 2,1
points (p<0,05), serum concentration of  FSH decreased from 56 ± 49 U/l to 36 ±
57 U/l, and level of 17b-estradiol increased from 27 ± 2 pg/ml to 44 ± 25 pg/ml.
Increasing of rCBF of 7,5 % was observed in ventricular right slice  and of 6,7 % in
the left one. rCBF  increase was stated in thalamic and cerebellar slices 3,3-5,2 %
(NS).
Conclusion: Hormonal replacement therapy increases regional cerebral blood flow.
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THE USEFULNESS OF CBF BRAIN SPECT IN FORENSIC MEDICINE
Piotr Lass, Maciej Piskunowicz, Maciej Krzyżanowski, Michał Studniarek
Departments of Nuclear Medicine, Forensic Medicine and Radiology,
Medical University of Gdańsk
INTRODUCTION: The aim of this study was to show the application of cerebral
blood flow SPECT scanning in forensic medicine expertise.
MATERIAL AND METHODS: CBF SPECT scanning has been performed in 12
persons: suspects, victims of crime and the subjects of civil court cases, using a
triple-head gammacamera MS-3 (Siemens) and 99mTc-HMPAO (Amersham) or 99mTc-
ECD (FAM, Lodz). Qualitative and quantitative analysis was performed, utilising an
asymmetry  index for unilateral perfusion deficits and a comparison to cerebellar
perfusion for assessing the regional cerebral perfusion. For assessing the normal
values two control groups: 30 patients studied utilising 99mTc-HMPAO (Amersham)
and 18 patients studied utilising 99mTc-ECD was studied.
RESULTS: At least in part of these cases CBF SPECT scanning proved its useful-
ness in medico-legal arguing and played a role in formulating the final forensic
expert’s opinion.
CONCLUSIONS: CBF SPECT scanning may play a role in forensic medicine, where
this method is mostly under-utilised at present. Its under-utilisation may be due to
the unsatisfactory co-operation of forensic and nuclear medicine specialists as well
as, at a high sensitivity, low to moderate specificity of CBF SPECT scanning.
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COMPARATIVE ASSESSMENT OF CLINICAL USEFULNESS OF TOTAL
PLASMA AND SPECIFIC HEPATIC CLEARANCE OF 99MTC-HEPIDA
I. Frieske*, J.Białkowska**, J.Kuśmierek*, J.Liniecki*, J.Kuydowicz**,
M.J.Surma*
* Department of Nuclear Medicine, Medical University of Lodz
** Chair and Clinical Department of Infectious Diseases, Medical University of Lodz
Introduction: Total plasma clearance of 99mTc-HEPIDA (ClPl) is one of noninvasive
tests, used in diagnostics of liver parenchyma disease. Its magnitude reflects func-
tional condition of the organ. Disadvantage of 99mTc-HEPIDA complex is its partial
elimination from the body via urinary system.
Unpredictable and pronounced variability of the fraction of 99mTc-HEPIDA that leaves
the body by urinary route may render assessment of liver’s excretory function – via
total plasma clearance determination – quite uncertain. For this reason a method
has been elaborated for determination of the specific hepatic clearance of 99mTc-
HEPIDA. The aim of the study was therefore a comparative evaluation of ClPl and
ClHp (specific hepatic clearance) for assessment of liver’s excretory function.
Materials and methods: The study was made on 96 patients with chronic disease
of the liver: hepatitis B and C, autoimmune hepatitis, parenchymal disorder of the
organ in course of alcoholic disease, and with hepatic cirrhosis. In addition, the
clearances in 31 healthy volunteers, in two age brackets: a/ 20-25 and b/ 50-55
years of age were also determined. In all subjects the measured values were stan-
dardized to the surface of the body = 1.73 m2.
The values of ClPl, varied from 65 to 312 ml (min 1.73 m
2)-1. Values of the specific
hepatic clearance (ClHp), expressed as a fraction of ClPl, varied from 29 to 98 %. For
values of both clearances four ranges were selected of equal span, and scores
were attributed to these ranges from 0 for the lowest to 3 for the highest.
Liver’s parenchyma performance was assessed on basis of five laboratory biochem-
ical tests applied commonly in hepatology (AspAT, AlAT, GGTP, bilirubin pl. conc,
proteinogram). Again for each test a range of equal span has been selected, attrib-
uting zero score to a physological (normal) range and up to 3 for most pathological
values. In turn, codependance was looked for between a sum of these scores and
those attributed to values of the clearances: a/ by means of covariance (Spearman
correlation) and b/ applying a c2 test for independance of the measures.
Results: There are strong negative correlations between sums of biochemical scores
and ClHp (r= 0.66) and ClPl (r =  -0.6).  Values  of c
2 test for ClHp and ClPl amounted to
67 and 44, respectively; they indicate again that accord between biochemical indices
of hepatic damage and 99mTc-HEPIDA clearance is better for ClHp than for ClPl.
Conclusion: The specific hepatic clearance ClPl reflects more adequately liver’s
parenchyma performance than the total plasma clearance (ClPl) of 
99mTc-HEPIDA.
DETERMINATION OF HEPATIC 99MTC-HEPIDA CLEARANCE BY MEANS
OF A SIMPLIFIED, SINGLE BLOOD SAMPLE METHOD
M.J. Surma
Department of Nuclear Medicine, Medical University of Lodz
Introduction: Hepatic clearance of 99mTc-HEPIDA is one of parameters for assess-
ment of liver’s excretory function, useful in diagnosis and monitoring of conditions
impairing integrity of the organ. However, there is no need to determine always the
clearance with high precision by means of serial blood sampling over the first 90
min. post injection of the radiopharmaceutical (RPh).
A less laborious, simplified procedure has been developed for determination of the
total plasma clearance  (ClPl) and of specific hepatic clearance (ClHp). The latter is a
difference between the ClPl and urinary (kidney) clearance ClUr of 
99mTc-HEPIDA.
Materials and methods: The study was made on a set of 165 clearance determi-
nations of 99mTc-HEPIDA in patients with varying degree of liver parenchyma dam-
age, using a multisample reference method.
Results: Based on the data from the determinations, several relationships were
derived enabling:
— determination of ClPl on basis of plasma concentration of the RPh, measured in
one sample of blood, drawn between 70 and 80 min post-administration;
— determination of ClUr utilising plasma concentration of 
99mTc-HEPIDA measured
in one sample of blood, and activity of the RPh, contained in a sample of urine
representing excretion over time from zero to 90 – 100 min post injection;
— calculation of ClHp as a difference ClPl-ClUr ,
— assessment of precision of 99mTc-HEPIDA clearances.
The value of ClPl and ClHp obtained from these simplified determinations correlate
very strongly with the values obtained by means of the multisample reference meth-
od (r = 0.96 for both ClPl and ClHp).
A dedicated computer program has been developed for calculations involved in
simplified clearance determinations.
Conclusions:
1. The developed simplified method for ClHp determination is simple and easy to
perform in every nuclear medicine lab. However, precision of the results is inferi-
or to that achievable by means of a multisample reference method, particularly
when the clearance to be measured has a value substantially below the normal
range.
2. The method, nevertheless, is suitable for screening of patients for presence of
liver parenchyma damage
P-GASTROINTESTINAL
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HEPATOBILIARY SCANNING IN THE DIAGNOSIS OF BILIARY ATRESIA
A. Kamińska, J. Pawłowska, I.Jankowska, E. Świątek-Rawa, P. Socha,
A. Kamiński, M. Teisseyre, P. Czubkowski, K. Toth
The Children’s Memorial Health Institute, Warsaw
Objectives: In the neonatal cholestasis the early diagnosis is vital. Therefor it is
essential to find the most sensitive and specific methods. Still, in most Polish paedi-
atric centres the standard is to perform hepatobiliary scanning. The aim of the work
is to assess the usefulness of hepatobiliary scanning in the diagnosis of biliary
atresia in our patients.
Material and methods: 33 hepatobiliary scannings done in 30 children with
cholestasis over the last two years were analysed. The mean age was 6,6 weeks.
The investigation was done with Multispect camera using intravenous infusion of
99mTc-MBrIDA.
Result: In 23 patients there was scanning done twice in the interval of two weeks.
The biliary atresia was proven during the operation and Kasai procedure was done.
In 2 children the second scanning showed bile drainage. In 3 children, apart from
the failing passage, the intrahepatic cholestasis was diagnosed.
Conclusions:
1. Hepatobiliary scanning in the diagnosis of neonatal cholestasis showed high
sensitivity (100%) but less specifity (74%).
2. In difficult cases the final diagnosis should be made from complex clinical, bio-
chemical and radiological techniques and, eventually, be verified by intraopera-
tive cholangiography.
PROPOSAL OF ALGORYTHM THAT MAKE POSSIBLE Q UANTITATIVE ESTI-
MATION OF HEMODINAMIC INDICATOR OF BLOOD SUPPLY IN LIVER AND
CALCULATION OF OXYGENE SUPPLY
Eugeniusz Żmuda
Szpital Specjalistyczny w Pile, Zakład Medycyny Nuklearnej,
Introduction: Despite a huge number of various laboratory examinations in lever diag-
nostics quantitative information is still not easy available. Those examinations inform
about processes taking place in organ. They appear in a miscanelous phases of dis-
ease providing to deep damages of organs. It has to be underlined that inflammation
processes or toxins effects on lever first of all disturb hemodinamics of an organ. Those
examinations most of all are the only one indicator of lever pathology when sharp period
of disease lefts serious damage of an organ which is not possible to detect by other
examinations.
The purpose of this work is to introduce an easy way of estimation of quantitative esti-
mation of circulation index via Arteria hepatis, portal vein, total blood circulation via lever
and oxygen supply indexes or both of catchement areas.
Materials: Examinations were applied to patients sent to ZMN with purpose of appreci-
ation after WZW. For examination was used sulfid coloid marked with Tc. Dynamic acvi-
sition was processed according to user protocol. After completing of examination it was
registered with a right side projection which is used for estimation of liver capasity.
Method: After statistic verification of repeatability of section inclination indicator which
belongs to liver artery as well as portal vein we stated the following way of proceeding:
1. Generation of dynamic curves from left heart ventricle, liver, right liver area
2. Estimation of maximum activity time on liver curve
3. Estimation of correction of deep indicator for organ location WKGN, indicators
of inclination of ascending part of left heart ventricle, liver artery ,portal vein  which
are useful for estimation of blood circulation indicators via Ah iVp, as well as
oxygen supply indicator.
4. Generally this algorithm is estimated with a help of 14 easy formulas. Function of
natural delogarythm was used only in one formula.
Calculation of proper values:
∑ total blood circulation via liver indicator =0,25 of circulating blood
∑ via liver artery = 0,05 o 0,075
∑ via portal vein = 0,2 to 0,175
∑ liver oxygen supply indicator = 20,5 to 20,75 (incl. Via liver artery = 4,5 to 6,75) via
portal vein from 16 to 14
Standard deviation is expressed in %of average value for lever artery parameters =6,4%
for portal vein =4,9%.
Conclusions: Described algorithm extends range of diagnostics of liver diseases with
calculation of chosen hemodynamic parameters and provides it’s quantitative estima-
tion when other parameters are  in the normal range.
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IS THE POLICLONAL IgG SPECIFIC TRACER FOR IMAGING
INFLAMMATION?
Z. Grabowski
Department of Nuclear Medicine County Hospital in Siedlce
INTRODUCTION In imaging of inflammation, espacially of bones, the policlonal
IgG is usefull and reliable tracer. It is thought to be specific for inflammation, but not
only for infection (for example inflammation of joints). Authors did not find any infor-
mation about concentration of IgG in bone metastases.
MATERIAL AND METHODS During rutine investigation of women with pelvic pain,
who 15 years before underwent mastectomy for carcinoma, we found intensive
uptake of MDP-Tc 99 in right iliac bone. In suspition of inflammation, we made an
examination with IgG. We found typical, intensive uptake of the tracer in this area,
and finaly diagnosis was osteomyelitis. Becouse it was clinical doubtfull, biopsy
was made. Histopatology showed metasis of carcinoma, probably from carcinoma
of the breast. That unexpected results inspired us to make another 3 examinations,
both with MDP and IgG in patients, who showed typical multiple metases to the
bones (2 with ca of the prostatae, 1 with ca of the breast).
RESULTS Scintigraphy with IgG already after 30 min. showed in all patients less or
more intensive uptake in metastases to the bones. It was almost imposible to difer-
entiate that uptake of typical uptake in  sites of inflammation.
CONCLUSIONS Therefore, instead of very limited number of patients, we made
preliminary conclusions. Uptake of policlonal IgG in metastases to the bones from
carcinoma of prostatae and breast is ofen. Probable machanism of that uptake is
the same as in the sites of  inflammation – polimerisation of IgG in extra vascular
space throught proteolitic enzymes, which are present in high concentration in car-
cinoma of prostatae and breast, as in the sites of iflammations. Therefore during
imaging of inflammation with IgG, that phenomenon should be taken into account.
DYNAMIC IMMUNOGLOBULIN G IN INFLAMMATORY LESIONS BONE-
-JOINT SYSTEM IMAGING BY SCINTIGRAPHY 99M TC-IgG
A. Stepien, J. Pawlus
Department of Nuclear Medicine, 5th Clinical Military Hospital, Krakow, Poland
Introduction: Usage radiofarmaceuticals which selective accumulation in the site
of the inflammatory allowed discovering pathology that cannot diagnosis by others
image methods. Scintigraphy 99mTc-IgG let distinguish between inflammatory le-
sions with and without active inflammation. Accumulation of IgG in the site of the
inflammation is non-specific and its mechanism is not clear. It is suggested that
increase vessels permeability plays the major role in localize IgG in the inflammato-
ry lesions.
The purpose of this study was to estimation dynamic IgG in the inflammatory le-
sion bone-joint system.
Material and methods: Scintigraphy IgG performed in 25 patients (110 inflamma-
tory lesions) with clinical confirmed active inflammatory process bone-joint system.
Study carried out with 99mTc labelled non-specific, policlonal immunoglobulin G (IgG)
(according to Bialobrzeskiej). Imaging gamma camera NuclineTN TH/AP performed
after 1, 4 and 22 hours since administration of the radiotracer.
Results: Kinetic IgG estimation on the basis of measurement activity lesions in
manual selected regions of interest (ROI) in the function time. Receipted value ac-
tivity/cm2 amended about background around inflammatory lesion and introduced
amendment on the radioactive disintegration 99mTc. In the all cases observed long-
lasting retention of the tracer in the inflammatory lesion with variable in time dynam-
ic. In analyzed group of patients stated 4 false positive lesions (3 changes post-
traumatic, 1 bone cancer). We did not observe differences in kinetic IgG between
false positive and false negative lesions.
Conclusions:
1. Presence the tracer in inflammation bone-joint system is long-lasting and char-
acterize slow remove IgG from lesion
2. Dynamic accumulation of IgG between 4 and 22 hour after administration of the
tracer is lesser in compare with the phase between 1 and 4 hour study
Conclusion, dynamic accumulation of IgG between 4 and 22 hours after injection
the radiotracer suggest that imaging in this time is optimal for visible inflammatory
changes in bones and joints.
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11C TRACER IN STUDIES OF NEW MATERIALS FOR SEMICONDUCTOR
DETECTORS OF IONIZING RADIATION
B. Petelenz, B. Rajchel, M. Bartyzel, R. Misiak, A. Adamski
The Henryk Niewodniczański Institute of Nuclear Physics, Kraków, Poland
Introduction. Ionic methods of surface modification can be used in forming super-
hard layers on working parts of endoprostheses or cutting (e.g. surgical) tools as well
as in semiconductor technology.
The aim of this work was investigation of boron-implanted diamonds as potential
materials for miniature thermoluminescence detectors of ionizing radiation, being
developed in our Institute for dosimetry in oncological radiotherapy.
Materials and methods. Polycrystalline diamond samples were implanted with
11B boron ions of 25 KeV energy. Surface density of the implanted boron was calcu-
lated from the measured charge deposited on the samples, and measured as the
activity of the positron emitter 11C (t1/2 = 20,38 min), produced in the samples in the
11B(p,n)11C nuclear reaction. The activations with the 14 MeV internal proton beam
were performed in the AIC-144 cylotron. The intensity of the 511 keV annihilation
peak of 11C was measured by gamma spectrometry.
Results. Proton activation is a very sensitive method of detecting isotopically sta-
ble 11B. Gamma-spectrometric measurements of 11C confirmed semi-quantitatively
the estimated density of implanted boron (ca. 1017 of 11B atoms cm-2). The accurate
analysis was difficult because of large errors in proton energy determination, but
these errors will be significantly reduced when the extracted beam becomes avail-
able.
Conclusions. Ionic implantation of boron into diamonds and diamond-like struc-
tures is a promising method of preparation of miniature semiconductor or thermolu-
minescence detectors.
Proton activation allows one to determine surface concentrations of 11B in materials
in which boron cannot be detected otherwise. It can be expected that deuteron
activation will be suitable for determining another stable isotope, 10B, e.g. in detec-
tors developed for boron neutron capture therapy.
Thick target yields of 11C produced in the 11B(p,n) reaction are high enough to con-
sider its application in preclinical research aimed at nuclear medicine (the target
material, B2O3,  is relatively cheap).
INFLUENCE OF INSULIN THERAPY METHOD ON THE INCIDENCE
AND PROGRESSION OF URINARY EXCRETION DYSFUNTION
IN TYPE 1 DIABETIC CHILDREN AND ADOLESCENTS
A. Szadkowska1, M.J. Surma2, E. Młodkowska2, J. Bodalski1
1 Institute of Pediatrics, Medical University of Lodz
2 Nuclear Medicine Department, Medical University of Lodz
Introduction: The aim of the study was to estimate the influence of the method of
insulin therapy on the incidence and progression of urinary excretion dysfunction.
Material  and methods: 112 patients ( 59 male, 53 female) at the age 13±3 years,
with duration of diabetes 5±3 years were included into the study. The individuals
were divided in to two groups. 63 patients were included into group I, treated by
conventional insulin therapy (CIT) and group II (59) for which the therapy was inten-
sified (IIT). The first renal scintigraphy (99mTc-EC) was performed in all patients when
they were treated conventionally. The second examination was  made after four
years in group I, while continuing the CIT, and in the group II treated intensively (IIT).
For characterization of the urinary excretion dysfunction we used a 3 grade classifi-
cation (type Z – normal result, type O1 – modest dysfunction, type O2 – severe
dysfunction). Metabolic control of diabetes was evalueted by means of glycated
haemoglobin (HbA1c) determined by high pressure liquid chromathography (HPLC)
four times  annually.
Results:  In the first renal scintigraphy the incidence of urinary excretion distur-
bances in both groups was similar. In group I the disturbances were found in 38,1%
children (in 18 - type O1 and in 6 - type O2), and in group II in 44,9% individuals (in
16 type O1and in 6 – type O2).  In the second examination we observed more
frequent incidence of urinary excretion dysfunction in group I (group I – II: 64,5% vs
28,6%, p<0,001). In that examination in 22 patients of group I the urinary excretion
disturbances or their progression were found, and only in one individual an im-
provement was observed. In group II in 13 children  the improvement, and only in 6
persons a deterioration was noticed. During first renal scintigraphy the level of met-
abolic control in both groups was similar (group I-II: - 9,8 vs 9,5%; ns). During four
years of observation in the group with intensified method of treatment (group II) the
metabolic control significantly improved in comparison to group I (group I - II; 9,2
vs. 8,1 p<0,001).
Conclusion: The intensification of the method of the insulin therapy in type 1 dia-
betic patients - by improvement of metabolic control  - may lead to reduction of the
incidence of urinary excretion disturbances.
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THE ROLE OF LYMPHOSCINTIGRAPHY IN THE DIAGNOSIS OF MALIG-
NANT TUMORS OF THE MOUTH, PHARYNX AND LARYNX
J. Manasterski*, R. Czepczyński, D. Kędzia*, W. Szyfter*, J. Sowiński,
A. Gracz**
Dept. of Endocrinology and Metabolism
*Dept. of Otolaryngology, Univ. School of Medical Sciences, Poznań
**1st Dept. of Oncological Surgery, Great Poland Cancer Center, Poznań
Introduction. Evaluation of the lymphatic system of the neck is subtancial for prop-
er choice of treatment in malignant tumors of the head and neck in N0 stage, i.e.
when regional lymph nodes are not palpable or by absence of lymph nodes greater
than 1 cm or sonographically heterogenous. Aim of this study was to evaluate the
usefulness of lymphoscintigraphy in the detection of the sentinel node in patients
with tumors located in oral, pharyngeal and laryngeal regions.
Material and methods. 7 patients (6 men, 1 woman; aged 42-66 years) treated for
lingual cancer (3 cases), pallatine cancer (1), tonsillary cancer (2) and laryngeal
cancer (2) in stage T1-3 M0 N0 were studied. Lymphoscintigrapy was erformed with
99mTc-nanocolloid (Nanocoll) with activity of 1 mCi (37 MBq),. The radiotracer was
injected submucosally, directly to the tumor. 15, 30, 60 and 120 min. p.i. acquisition
of images of the neck were performed using Nucline gamma camera (Mediso). The
visualised lymph nodes were excised and examined histopathologically.
Results. In all the patients one to four sentinel lymph nodes in the neck were visu-
alized. Pathological examination revealed metastatic cells only in one of the pa-
tients – in this case metastases were found not only in this lymph node but also in
other nodes that were not visualised by this method. In the remaining patients no
malignant cells in the sentinel nodes were found. During follow-up (4 – 1 months
after surgery) a local recurrence was found only in one patient in whom the removed
lymph nodes were not metastatic.
Conclusion. Lymphoscintigraphy is an efficient method for localization of sentinel
lymph nodes in case of the tumors of oral, pharyngeal and laryngeal region in stage
N0. The obtained results are encouraging, so that the studies will be continued in
a larger group and the presented method probably will be introduced to the routine
clinical practice.
EVALUATION OF THE LYMPHATIC DRAINAGE
OF THE THYROID TUMORS USING LYMPHOSCINTIGRAPHY
R. Czepczyński, M. Ruchała, M. Bączyk, J. Sowiński
Dept. of Endocrinology and Metabolism, Univ. School of Medical Sciences,
Poznań, Poland
Introduction. Evaluation of the lymphatic drainage of a tumor is of great impor-
tance while planning the extent of a surgical treatment. Lymphoscintigraphy is one
of the methods used for the assessment of the lymphatic drainage. In this study, we
assessed the usefulness of lymphoscintigraphy in the preoperative evaluation of
patients with thyroid tumors suspected of malignancy.
Material and methods. 11 patients in whom a solitary thyroid nodule was found by
the means of ultrasound examination and in whom the fine needle biopsy revealed
papillary thyroid carcinoma (5 patients) or follicular nodule (6 patients). Before thy-
roidectomy a lymphoscintigraphy was performed. An activity of ca. 1 mCi (37 MBq)
of Tc-labelled nanocolloid (Nanocoll®) was injected into the thyroid nodule with the
use of a fine needle (0,35 mm diameter). The injection was supervised by the  ultra-
sound imaging. Scintigraphy of the neck was then performed in four phases: phase
1 - 2 min. p.i., phase 2 - 1 h p.i., phase 3 - 2 h p.i., phase 4 - 3 h p.i. The images
obtained were analysed for focal activity around the tumor, i.e. outside the injection
site.
Results. In 2 patients (18,2%) no focal activity outside the tumor was found in any
phase of imaging. In the remaining 9 patients (87,8%) altogether 54 extratumoral
foci accumulating the tracer were found. In 8 out of 9 patients the first focus (the
sentinel node) was observed already in the early images of phase 1. In each next
phase of the imaging new foci (lymphnodes) were visualised. In all the study group,
the images in phase 1 revealed 20 lymphnodes, in phase 2 - 29 lymphnodes, in
phase 3 - 50 and in phase 4 - 54 lymphnodes.
Conclusion. In the majority of patients lymphoscintigraphy is able to localise the
sentinel node as soon as in several minutes after injection of the tracer into the
thyroid tumor. This method can be successfully used in the evaluation of the lym-
phatic drainage in patients operated for diagnosed or suspected thyroid carcino-
ma.
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DYNAMIC LYMPHOSCINTIGRAPHY IN DIAGNOSTIC AND MANAGEMENT
OF POSTMASTECTOMY LYMPHOEDEMA
Bączyk M., *Bieda J., Wyszomirska A., Czepczyński R., Sowiński J.
Dept. of Nuclear Medicine and *Lympoedema Out-patients Clinic
University School of Medical Sciences Poznan, Poland
Introduction. Postmastectomy lymphoedema develops in 20-36% of women after breast cancer
surgery with axillary clearance. In many cases lymphoedema delays full recovery and influence
physical and psychosocial well-being.
Objective. The aims of the study were:
— to evaluate dynamics of the lymph outflow in patients after axillary clearance for breast cancer
with subsequent lymphoedema
— to define the level of lymphatic insufficiency and its influence on effects of complex decongestive
therapy (CDT)
Materials and methods. The group of patient consisted of 16 women. The age of patients varied
from 37 to 65 years. Dynamic lymphoscintigraphy was taken with Varicam gamma camera by  Els-
cint. 0,5 ml of the radiotracer (Nanocoll labelled with 99m Tc) was injected subcutaneously between
II and III metacarpal bone at the back of the hand. Subsequent acquisitions were taken every 60
sec., radioactivity over axillary, sub- and supraclavicular lymph nodes area was evaluated.
Registered parameters:
— arrival time - the time from radiotracer injection to revealing regional lymph nodes.
— lymph nodes uptake - storage capacity of the radiotracer in the regional lymph nodes in %.
During examination patient was doing movements of flexion and extension in the wrist to activate
muscle pump. The examination was ended by final scintigraphy after 2 hours or if necessary after 5
hours by scintigraphy evaluating dermal back flow. Lymphatic insufficiency was measured in 4
steps scale by Weissleder and compared with clinical grading and effects of CDT.
Results. There were three types of images registered:
— no axillary lymph nodes revealed and flat radioactivity curve. This corelated with severe lymphoe-
dema in clinical grading and poor results of CDT.
— a few lymph nodes revealed in the axilla with marked outflow to the subclavicular lymph nodes
and delayed transport of the radioactive material. It correlated with moderate lymphoedema in clin-
ical grading and slightly better effects of CDT.
— direct although delayed lymph outflow to the supraclavicular  lymph nodes. Those patients had
clinically mild lymphoedema and achieved the best results in CDT.
Conclusions. Dynamic lymphoscintigraphy helps not only to evaluate the level of lymphatic insuf-
ficiency but also to estimate remaining transport capacity and the role of muscle pump in accelerat-
ing lymph outflow. Those factors are strong predictors in the treatment efficacy. Lymphoscintigra-
phy should be done immediately when the first symptoms of lymphoedema occurs. The delay in
proper treatment results in massive fibrosis in subcutis that compromises the lymph outflow in
remain intact lymphatics.
EVALUATION OF THE RADIOTRACER FLOW BY LYMPHOSCINTIGRAPHY
IN PATIENTS WITH SECONDARY LYMPHOEDEMA
A. Stępień, J. Pawlus
Department of Nuclear Medicine, 5th Clinical Military Hospital, Krakow, Poland
Introduction: Lymphoedema is clinical after-effect functional and anatomical in-
sufficiency of lymphatic vessels. Disturbance balance between capillary filtration
(production lymph) and its outflow, cause accumulation of the fluid in tissues and
migration cells. Untreated lymphatic oedema lead to deepen dysfunction of the
limbs, skin ulceration and in extreme cases even cancers (lymphangiosarcoma). In
the Europe the major reason lymphoedema are chronic insufficiency veins in the
lower limbs, concern about 25-33% women and 10-20% men, cancer diseases and
surgical treatment. Efficacy and a relatively non-invasive diagnostic method allow
to evaluate of lymph transit is lymphoscinigraphy.
The purpose of this study was to estimation of rate and size of the radiofarmaceu-
tical flow in cases secondary lymphoedema by lymphoscintigraphy.
Material and methods: Retrospective analysis included 21 patients with unilateral
oedema the upper limb after lymphoidectomy. After subcutaneous injection of 99mTc
labelled albumin (Nanoalbumon) into second interdigital space each hand, study
was performed.  All subjects underwent an initial dynamic acquisition (gamma cam-
era NuclineTN TH/AP) of the upper limbs for 30 min, with further images obtained
after 2 hours. We selected regions of interest (ROI) and drew curves activity in func-
tion time. The diagrams normalized about administration of the radiotracer.
Results: The lymphatic transport of the tracer was compared between hand with
lymphatic oedema and hand without (normal), according differences in time of in-
jection and activity. The rate and size the tracer transports in that group of patients
was differentiated. Accelerated flow was observed in 14,3%, slowed in 38,1% and
symmetric in 46,6% cases. The features block of the lymph outflow in dynamic
phase of the study was visible only in the regions, which showed retention of the
tracer in delay phase of the study. In 74% cases size of oedema in clinical study did
not correlate with region retention of the tracer in static analysis.
Conclusions:
1. The rate and greatness transit of the tracer in patients with secondary oedema in
dynamic phase was differentiated.
2. Accelerated and symmetric of the tracer flow did not exclude lymphatic ground
of the oedema.
3. The block in the outflow obtained for regions, which demonstrated prolong
retention of the radiotracer.
4. We have not observed connection between spread of the oedema in clinical
examination and region retention of the tracer.
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INFLUENCE OF THE ACQUISITION TIME ON THE RESULTS
OF DIAGNOSTIC STUDIES WITH 131I IN PATIENTS WITH
DIFFERENTIATED THYROID CANCER
W. Mielcarek 1, Z. Stembrowicz-Nowakowska1, E. Dziuk1, A. Kowalczyk2,
M. Siekierzyński2
1Centre of Nuclear Medicine and  2 Endocrinology and Radioisotope Therapy
Clinic,
Central Clinical Hospital WAM, Warsaw
Introduction. Detection of the thyroid remnants or metastases in patients with dif-
ferentiated thyroid cancer may be dependent on various factors (e.g. sufficient level
of the TSH stimulation, radioiodine dose, period after radioiodine administration
and imaging time, proper procedure to avoid artifacts, equipment). The aim of this
work was to assess the utility of an additional, 15 minutes long anterior and poste-
rior scan of the neck and thorax region.
Material. The group of patients with finally positive results of the diagnostic scintig-
raphy consisted of 24 persons (M-3, F-21) aged 27 - 77 yrs (mean 50,9), 22 of them
with papillary cancer, 2 follicular cancer.
Methods. Whole-body scans (WBS) were performed using dual headed gamma
camera Varicam equipped with high-energy collimators. Acquisition time was up to
30 minutes which corresponds with 5 minutes scan of the neck region. Doses ranged
from 3 to 5,5 mCi of 131-I (mean 3,8 mCi 131-I). Additionally, 15 minutes long pla-
nar studies of the neck and thorax were performed.
Results. The foci of increased activitity were detected in 18 out of 24 WBS. The
remaining 6 patients had changes visible only in 15 minutes long additional study
(in 2 evident, in 4 faintly seen) so that additional, longer scans detected remnants
not seen on WBS alone in 25 % patients in this investigated group.
Conclusion. Taking into consideration also lower doses of radioiodine used in
diagnostic scintigraphy WBS without additional, longer scan may underestimate
the presence of thyroid remnants.
COMPARISON OF TC-99M DUAL-PHASE MIBI SCINTIGRAPHY VERSUS
TC-99M/TC-99M-MIBI SUBTRACTION SCINTIGRAPHY IN THE DIAGNOSIS
AND LOCALIZATION OF HYPERFUNCTIONING PARATHYROID GLANDS
IN SECONDARY AND TERTIARY HYPERPARATHYROIDISM
M. Kobylecka 1, J. Miśkiewicz1, A. Zdrodowski 1, W. Chudziński2, L.Królicki1
1Nuclear Medicine Department, Warsaw Medical University
2Klinik of General, Vascular and Transplant Surgery Warsaw Mecical University.
Background: The MIBI perfusion scintigraphy is reported to be more sensitive than
other diagnostic modalities in the preoperative parathyroid localization studies. The
double-phase scintigraphy with Tc-99m-MIBI is the preferred protocol for the dis-
eased glands localization, however the optimal procedure for parathyroid scanning
has not been defined. Dual phase MIBI scintigraphy, based on the difference in
99mTc-MIBI clearance rates between the thyroid and diseased parathyroid glands,
is the most sensitive in primary adenoma localization (65-83%). On the contrary,
there is a high rate of false negative results in patients with secondary hyperplasia.
The subtraction technique might be helpful in these cases.
Aim: The study compared the relative sensitivity of these two techniques of par-
athyroid diseased gland localization.
Material and methods: We examined 76 patients with secondary and tertiary hy-
perparathyroidism. The double-phase 99mTc-MIBI perfusion scintigraphy was per-
formed in all 76 patients. The subtraction 99mTc/99mTc-MIBI scintigraphy was per-
formed in 46 patients.
Results: The dual phase 99mTc-MIBI scan and the 99mTc/99mTc-MIBI subtrac-
tion scan was positive in 16 (22%) of 73, and 28 (61%) of 46 cases, respectively.
The lesions, which were evaluated in the subtraction scan only, showed no pro-
longed retention of the tracer in comparison to thyroid tissue.
Conclusions:
1. The subtraction imaging was more sensitive than the double-phase technique in
our group of patients.
2. The subtraction allows the evaluation of the pathological parathyroid glands with
atypical washout, which do not show the prolonged retention of the tracer.
3. The delayed images of double-phase protocol do not provide any additional
information in comparison to early MIBI image and thyroid pertechnetate sub-
traction.
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CONNECTION BETWEEN PRESENCE OF THYROID LESIONS AND
RESULT OF 99M-TC MIBI SCINTIGRAPHY IN PATIENTS WITH
SECONDARY AND TERTIARY HYPERPARATHYROIDISM
M. Kobylecka 1, J. Kunikowska1, J. Miśkiewicz 1, W. Chudziński2, L.Królicki1
1 Nuclear Medicine Department, Warsaw Medical University
2 Clinic of General, Vascular and Transplant Surgery, Warsaw Medical University.
Background: The low sensitivity of 99m-Tc MIBI scintigraphy in patients with second-
ary and tertiary hyperparathyroidism may be connected with common occurrence of
thyroid abnormalities in goiter endemic area and with thyroid hormone disturbances
present in dialyzed patients.
Aim: The study compared the sensitivity of the double-phase and subtraction MIBI
perfusion scintigraphy in patients with and without thyroid abnormalities. Material and
methods: 48 patients with secondary and tertiary hyperparathyroidism were exam-
ined. 17/48 patients had goiter or focal thyroid lesions. The double-phase 99mTc-MIBI
perfusion scintigraphy and the subtraction were performed in all patients. At least one
focus of abnormal MIBI accumulation was considered positive. We analyzed the re-
sults of each scintigraphical protocol in both groups of patients: with and without thy-
roid abnormalities.
Results:
Dual phase Subtraction
scintigraphy
Positive Negative Positive Negative
Goiter and/or thyroid 2/17 15/17 9/17 8/17
focal lesions (17)   (12%)  (88%)  (53%)  (47%)
Normal thyroid (31) 11/31 20/31 21/31 10/31
 (35%) (65%)  (68%)  (32%)
The dual phase 99mTc-MIBI scan and the 99mTc/99mTc-MIBI subtraction scan was
positive in 13/48, and 28/48 cases respectively. In the group of patients with thyroid
lesions the sensitivity of dual-phase and subtraction scintigraphy was lower than in the
group without thyroid lesions. For dual phase scintigraphy the difference between this
two groups was statistically significant.
Conclusions:
1. The subtraction imaging should be routinely performed in patients with secondary
and tertiary hyperparathyroidism due to common occurrence of thyroid abnor-
malities.
2. The subtraction improves the results in both groups of patients.
3. Thyroid abnormalities are important, but not the only reason of false negative
results of scintigraphical examinations.
DIAGNOSTIC ACCURACY MAMMOGRAPHY AND SCINTIMAMMOGRA-
PHY IN DETECTION OF PRIMARY BREAST CANCER RELATED TO SIZE
OF THE TUMOUR
Agnieszka D. Kolasinska, John R. Buscombe, Sławomir Chaberek, Jaroslaw B.
Ćwikła, Brian Holloway, Tim Davidson, Santilal Parbhoo, July Cowe,
Andrew J.W. Hilson
Department of Nuclear Medicine, Radiology and Surgery; Royal Free Hospital;
London, NW3 2QG; UK
INTRODUCTION: The detection of breast cancer relies on physical examination
performed by trained oncologistand mammography (XMM). The sensitivity of mam-
mography is often without typical microcalcification lesions-size dependent. The
use of scintimammography (SMM) may be helpful in this situation.
THE AIM OF THE STUDY is to compare the diagnostic accuracy of mammogra-
phy and scintimammography in patients with suspected breast cancer across all
groups with different size lesions.
MATERIALS AND METHODS: There were 304 patients with suspected breast
lesions recruited from Symptomatic Breast Clinic Royal Free Hospital. Standard
XMM and SMM (Tc-99m sestaMIBI) were performed in every patients. Analysis of
images were performed by trained specialists in their fields. Each imaging study
was graded using five grades of certainty, as follows: 1- normal or benign, 2- prob-
ably normal or benign, 3 equivocal, 4 – probably cancer and 5 – cancer. All lesions
were surgically removed and final histology and pathological size of the tumours
were reviewed. Three groups of lesions were analysed: below 2cm, between 2-4cm
and above 4cm.
RESULTS: There were 230 patients with breast cancer and 74 patients with benign
lesions. First group consists of: 86 patients (69 cancers), second group consists of
147 patients (107 cancers) and third group had 71 patients (54 cancers).
Sensitivity of SMM was consistently high across all size groups of the lesions; over-
all sensitivity for SMM was 87% compared to 69% for XMM. Sensitivity of SMM
consider first group of patients provides results as follows: SMM 77% and XMM
54%; second: group of patients SMM 88% and XMM 68% and third SMM 100% and
XMM 91%. Using ROC analysis the results were as follows. In first group there was
no significant differece between diagnostic accuracy of SMM and XMM (Wilcoxon
matched pairs test p>0,05). In second group of patients SMM had higher diagnos-
tic accuracy than XMM p<0.05 with 90% of probability and third group had no
significant difference between SMM and XMM (p>0.05).
CONCLUSION: SMM seems to be a sensitive and reliable diagnostic test for breast
cancer independent of the size of the tumour, particular in group of patients pre-
sented tumour size between 2 and 4cm.
COMPARISON OF STANDARD TRIPLE ASSESSMENT AND SCINTIMAM-
MOGRAPHY IN DETECTION OF PRIMARY BREAST CANCER
Agnieszka D. Kolasinska, John R. Buscombe, Jaroslaw B. Ćwikła, Brian
Holloway, Tim Davidson, Santilal Parbhoo, July Cowe, Andrew J.W. Hilson
Department of Nuclear Medicine, Radiology, Surgery and Pathology. Royal Free
Hospital; London, NW3 2QG; UK
INTRODUCTION: Although triple assessment is currently the gold standard for
diagnosis of primary breast cancer, still open biopsies are required in many cases
to confirm diagnosis. Scintimammography (SMM) could be an alternative imaging
technique for inadequate fine needle aspiration cytology (FNAB).
AIM OF THE STUDY: To compare the sensitivity of the traditional triple assess-
ment of symptomatic breast lesion with scintimammography and to evaluate the
accuracy of SMM in cases of inadequate fine needle aspiration cytology.
MATERIALS AND METHODS: There were 320 patients with suspected breast
lesions recruited from symptomatic breast clinic. Mean age of women was 51 year
(SD 12). Scintimammography was performed in each patients followed by stan-
dard X-ray mammography (XMM). There were 402 fine needle biopsy performed in
all patients. Core biopsy or excision of suspected lesion were performed if any of
modalities suggested malignancy or there were still clinical suspicious of malignancy.
RESULTS: Histopathology verified cancer in 199 patients and benign lesions in
121 patients. FNAB was truly positive in 171 of 199 primary malignant breast can-
cers (86%) and false negative in 28 cases. There were 25 false positive cases of fine
needle biopsy. XMM was truly positive in 140 of 199 cancers (70%). SMM was
correct in 181 of 199 cancers (91%). The overall sensitivity of standard triple as-
sessment was 93%. The specificity of each modality was as follows: FNAB 70%;
XMM 68%; SMM 65%, and triple assessment only 54%. In those patients with false
negative results of FNAB, scintimammography confirmed malignancy in 22 of 28
cases (79%). Also in group with false positive fine needle biopsy SMM excluded
cancer in 18 of 25 cases (72%).
CONCLUSSION: Scintimammography seems to be sensitive and more specific
than the combined traditional triple assessment for diagnosis of malignant breast
cancer and especially it is very useful in evaluation of those lesions in whom triple
assessment and FNAB are equivocal, doubtful or incorrect.
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COMPARISNON OF DIAGNOSTIC ACCURACY BETWEEN MAMOGRAPHY
AND SCINTIMAMMOGRAPHY IN PATIENTS WITH PRIMARY BRAEST
CANCER RELATED TO THEIR AGE
Jaroslaw B. Ćwikła, John R. Buscombe, Sławomir Chaberek,
Agnieszka D. Kolasinska, Brian Holloway, Tim Davidson, Santilal Parbhoo,
July Cowe, Andrew J.W. Hilson
Department of Nuclear Medicine, Radiology and Surgery; Royal Free Hospital;
London, NW3 2QG; UK
INTRODUCTION: Detection of breast cancer relies on clinical examination, mam-
mography (XMM) and histopathology. However, where mammography has reduced
sensitivity, such as in younger women, with dense breasts or receiving HRT, the inclu-
sion of scintimammography (SMM)  may aid diagnosis.
AIM OF THE STUDY: We compared the diagnostic accuracy of the combination of
XMM and SMM with either test alone, across all age groups.
MATERIALS AND METHODS: Data for 458 patients (above 50 year old 247 pa-
tients), imaged for suspected breast cancer. In all cases, further information had been
required due to inconclusive mammography results and/or discrepancies between
mammography and breast examination. All patients had core or surgical biopsy to
confirmed pathology. All images were graded using five grades of certainty. SMM
images were reviewed by an independent specialist blinded to clinical presentation
and XMM. Diagnostic accuracy of each test, overall and by each age subgroup, was
compared using ROC curve analysis.
RESULTS: The sensitivity of the combination of SMM and XMM in all patients was
higher than mammography or SMM alone,  respectively 92%, 67%, 87%. In the group
of patients below 50 yo the sensitivity were as follows: 95%, 68%, 90% and in group
above 50 were respectively: 91%, 65%, 84%. The specificity for combination of SMM
and XMM in all patients were 60%, for XMM alone 73%, for SMM alone 72%. In the
group of patients below 50 the specificity were respectively: 66%, 73%, 65%, in the
second group of patients above 50 yo– 61%, 72%, 77%. Analysis of the area under the
ROC curves showed that the combination resulted in improved diagnostic accuracy
compared with XMM alone, in all patients (p<0.05 with 90% certainty).and in group of
patients below 50 yo (p<0.05 with 90% certainty). In the group of patients above 50 yo
there was significance difference between the combination of SMM and XMM and
XMM alone (p=0,05 with 80% certainty). There was no difference in the diagnostic
accuracy between XMM and SMM alone in both groups of patients. However, there
was significance difference analyzing all patients (p=0.05 with 90% certainty).
CONCLUSION: This study shows that the combination of both imaging modalities
improves diagnostic accuracy than each technique alone in detecting primary breast
cancer in all patients as well as in two groups above 50  and below 50 years old
patients.
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UPTAKE OF RADIOLABELED ALPHA-FETOPROTEIN (AFP) AND ITS PEP-
TIDE FRAGMENT BY EXPERIMENTAL BREAST CANCER
R. Wiercioch 1, G. Birnbaum2, E. Byszewska2, M. Mirowski1,2
1 Department of Pharmaceutical Biochemistry, Medical University of Lodz, 2
Radioisotope Centre, POLATOM, Otwock, Świerk. Poland
Introduction. The presence of alpha-fetoprotein receptor (r-AFP) is observed in
tumor cells which can be characterized by high grade of proliferation. This fact is
the basis of the study in which human AFP as a vector for anticancer drug targeting
(bleomycine, doxorubicine, cis-platine, methotrexat and others) is used. Conjugates
all of this compounds with AFP demonstrate high selectivity in drug delivery to tu-
mor cells. Therapeutical effect of this conjugates comparison with free drugs was
significantly better. The aim of this study was to check the usefulness of AFP in
scintigraphy of breast cancer  and selection of its peptide fragment responsible for
binding with r-AFP.
Materials and methods. Synthetic, 34 amino acid AFP peptide fragment (EEDKL-
LACGEGAA DIIIGHLCIRHEMTPVNPGVGQY-COOH) was synthesized at The Na-
tional Research Centre for Biotechnology in Braunschweig, Germany. Labeling of
investigated molecules by iodine 131 was carried out in Radioisotope Centre PO-
LATOM. Mice (C3H/Bi) with transplantable mammary tumors were used in biodistri-
bution studies.
Results. The percentage of accumulation (% of dose / gram of tissue) of  131I-AFP
in tumor tissue in in vivo experiments at time intervals (0,5, 2, 24 and 48 hours after
injection) was 4.02, 5.43, 0.28 and 0.15 respectively. Tumor to muscle (T/M) radio-
activity ratio  was estimated as 5.7, 3.4, 1.7 and 23.4. The content of 131I-AFP pep-
tide fragment in tumor tissue after 0.5, 2 and 24 hours was 2.29, 5.56 and 0.21%. T/
M ratio was the highest (47.5) after 30 minutes, later decrease tendency was ob-
served (5.6 after 2 hours, and 3.2 after 24 hours).
Conclusions. Percentage of 131I-AFP and its 34 amino acid peptide fragment ac-
cumulation in tumor tissue was nearly the same. However, T/M radioactivity ratio
was higher for peptide fragment of AFP. Our data suggest, that selected peptide
fragment is responsible for binding with r-AFP.
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PROGRESSIVE FACIAL HEMIATROPHY: CENTRAL NERVOUS SYSTEM
INVOLVEMENT IN HM-PAO-SPECT AND MRI IMAGES
Królicki L., Błaszczyk I., Krasuń M., Butkiewicz O.
Dep, of Nuclear Medicine and Dep. of Dermatology, Medical School, Warsaw.
Background. The atrophies in progressive facial hemiatrophy (PFH) show such
clinical similarity to involutionary deep morphea, that the relationship of these two
conditions is not clear and not infrequently controversial.
Objective. The aim of the study was to find out relationship of PFH and scleroder-
ma en coup de sabre by establishing the presence and type of central nervous
system (CNS) involvement in both diseases.
Material. The study was performed in 19 cases of PFH classified into two groups:
group 1 in which atrophies were preceded by cutaneous indurations
(ten cases) and group 2 (nine cases) with no preceded indurations. The third group
consisted of seven cases of scleroderma en coup de sabre.
Methods. Besides the neurological examination following techniques were applied:
electroencephalography (EEG), magnetic resonance imaging (MRI) before and af-
ter contrast injection to evaluate the integrity of blood-brain barrier, angio-MR to
evaluate intracranial blood vessels anomalies and 99mTc-HM-PAO-SPECT to eval-
uate regional cerebral blood flow (CBF).
Results. The studies with the use of different techniques disclosed similar anoma-
lies in all three groups. MRI did not show abnormality in 2 of 9 PFH cases preceded
by indurations, in 5 of 9 cases not preceded by indurations and in all 7 cases of
scleroderma en coup de sabre, in majority of which SPECT showed regions of
diminished cerebral blood flow. However in some cases SPECT was normal and
MRI abnormal. Angio-MR was not contributory disclosing the same type of abnor-
malities of Willis circle in controls. The  blood-brain barrier was damaged in single
cases of PFH, as disclosed by MRI with contrast.
Conclusion. The study showed a very frequent CNS involvment in PFH cases,
both preceded and not preceded by cutaneous indurations, and with or without
coexistent plaques of localized scleroderma elsewhere on the body, as well, as in s.
en coup de sabre. The results of CNS studies with the use various techniques speak
in favor of close relationship between PFH and scleroderma. Of practically impor-
tance is detection of abnormal SPECT  by normal MRI in some cases of PFH and in
s.en coup de sabre, which indicates the usefulness of SPECT in the study of these
conditions.
BRAIN SPECT IMAGING AND HEMISPATIAL NEGLECT IN RIGHT
HEMISPHERE-DAMAGED PATIENTS
Piotr Lass, Krzysztof Jodzio, Walenty Nyka, Dariusz Gąsecki, Justyna Scheffler
Department of Nuclear Medicine, Department of Neurology, Medical University of
Gdańsk, Department of Psychology, University of Gdańsk
BACKGROUND: Hemispatial neglect, characterised as failure to attend to con-
tralesional space, is hypothesised by recent neuroanatomical models to result from
damage to a network involving the frontal, parietal, and cingulated cortices, basal
ganglia, and thalamus.
METHODS: The aim of this preliminary study was to verify this model of neglect in
twenty two right hemisphere-damaged acute stroke patients using single photon
emission-computed tomography (SPECT). Presence of a single right-sided vascu-
lar brain lesion was confirmed on CT and/or MRI. Neglect, assessed with a battery
of drawings, line bisection, and line and shape cancellation tests, was observed in
12 cases.
RESULTS: Patients with neglect (compared with those without neglect) had more
extensive hypoperfusion in the frontal and parietal cortex, as well as striatum and
thalamus. Left-sided dysfunction in the parietal cortex and the thalamus also emerged
as significantly associated with neglect on SPECT imaging. Moreover, performance
on three out of five tasks (the drawing tests and line bisection test) commonly used
to detect the presence of hemispatial neglect was exclusively sensitive to damage
to the parietal cortex of the right hemisphere, while the line cancellation test might
be attributable to the lesion of the right striatum.
CONCLUSIONS: This findings support the model attributing neglect to a unilateral
defect in a cortico-striato-thalamo-cortical loop. It can be concluded that the brain
SPECT imaging provides a reliable description of the brain pathology associated
with hemispatial neglect.
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CBF 99MTC-HMPAO BRAIN SPECT IN ANTIPHOSPHOLIPID SYNDROME
Piotr Lass, Grzegorz Romanowicz, Mirosława Koseda-Dragan, Roman Nowicki,
Jarosława Lauer, Justyna Scheffler
Department of Nuclear Medicine, Medical University, Gdańsk, Poland
BACKGROUND: Antiphospholipid syndrome (APS) is defined as the presence of
repeated episodes of arterial and venous thrombosis, recurrent spontaneous abor-
tions and thrombocytopenia with elevated antiphospholipid antibodies. An impor-
tant feature of APS are cerebrovascular disorders of thrombotic origin. The aiom of
the study was to assess cerebral blood flow changes utilising brain SPECT scan-
ning.
METHODS: CBF SPECT scanning was performing using 99mTc-HMPAO (Amer-
sham, UK) and a triple head gamma-camera MS-3 (Siemens, Erlangen, Germany)
in 21 patients with APS: 12 with systemic lupus erythematosus, 4 with Sneddon’s
syndrome, 2 with Sjögren’s syndrome, 2 with primary APS, 1 with HELLP syndrome.
30 healthy volunteers served as a control group.
RESULTS: 20 studies were abnormal, 1 normal. Abnormalities comprised multifo-
cal perfusion deficits and diffuse regional CBF defects. The average number of
focal perfusion deficits per patients was 4.8 ± 1.7. In 7 patients multifocal frontal
perfusion deficit was accompanied by diffuse frontal hypoperfusion (bilateral hypo-
frontality), in 1 by temporal and occipital hypoperfusion. Analysing the group as a
whole, a decreased perfusion in frontal lobes, thalami and basal ganglia has been
found. A significantly higher was the number of focal perfusion deficits was higher
in patients with cognitive impairment (8.7 ± 2.2), as well as in patients  with stub-
born migraneous headaches (6.7 ± 2.6).
CONCLUSIONS: These results indicate the high utility of brain SPECT CBF stud-
ies in patients with antiphospholipid syndrome.
EFFICACY OF 99MTC-IGG SCINTIGRAPHY IN DETECTION OF ACUTE
NEONATE OSTEOMYELITIS
E. Młodkowska*,  A. Midel**, T. Biegański**
* Department of Nuclear Medicine, Medical University of Łódź
** Department  of Radiology, Center of Mothers Health of Łódź
Introduction: The acute neonate osteomyelitis starts in epiphysis of a long bone,
from where it diffuses into the neighbouring joint. The disease is frequently of a
multifocal character, occupying simultaneously or spreading to several bones and
joints. Detection of inflammatory foci presents a difficult diagnostic problem with
which ultrasonography, classic radiology, nuclear medicine, magnetic resonance
imaging and computerized tomography try to deal with.
Objective of the study was to assess the  efficacy of scintigraphy using a 99mTc
labeled immunoglobulin G (99mTc-IgG) complex for detection of the inflammatory
foci in the skeleton in neonates and  infants.
Materials and methods: 29 children were studied, of the age ranging from 5 to 30
days (mean ~ 15 d), on the average in the second week of the disease. Whole body
scintigraphy (anterior and posterior) was performed at 4 and 24 hours post admin-
istration of 40-80 MBq of the radiopharmaceutical.
Results: Out of 44 foci verified positively by means of above mentioned imaging
modalities, and/or by means of surgery, microbiology and histology, 37 were diag-
nosed correctly by 99mTc-IgG scintigraphy. The resulting sensitivity and postive pre-
dictive value of the test amounted to 84 and 90 per cent, respectively. In 3 neonates
it was only the scintigraphy that yielded clinically „silent” inflammatory skeletal foci.
There were 4 false positive results of which one resulted from presence of
a verified suppurative focus of soft tissues.
Conclusion:
1. The results of the study indicate that the whole body 99mTc-IgG scintigraphy is
an efficacious method for detection of acute osteomyelitis in neonates and
infants.
2. The test provides diagnostic informations regarding the stage of the disease,
additional to those obtainable by other means.
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COMPARISON OF THE USEFULNESS OF LUNG PERFUSION SCINTIGRAPHY
AND HIGH RESOLUTION CT IN THE DIAGNOSIS OF PULMONARY
EMBOLISM — PRELIMINARY REPORT
J. Kunikowska, L.Królicki, M.Kobylecka
Nuclear Medicine Department, Warsaw Medical University
Background: Despite technical progress, the diagnosis of pulmonary embolism (PE)
remains challenging. Even pulmonary angiography does not guarantee perfect diag-
nosis accuracy, as 5-10 % of studies are false negative. The aim of study was  to
compare perfusion scintigraphy using planar and single photon emission computed
tomography (SPECT) techniques and spiral computer tomography (CT) in clinically
suspected PE.
Material and methods: 34 patients with clinical suspicion of pulmonary embolism
were investigated. Following scintigraphy 9 patients were given antithrombotic treat-
ment and CT was performed within a week. Both lung scan and CT were available for
final analysis in  25 patients (16 women, 9 men, avg. age 72.72 ± 8.9 years). Investi-
gations using planar and SPECT methods were made with two-head Elscint gam-
macamera, using 99m Tc  labelled human albumin microspheres, with 300-400 MBq
activity. Data were acquired in 72x20s mode. Lung scans were evaluated using PIO-
PED criteria.
Spiral CT scans were performed using radiologic contrast (Picker PQ 2000)
Results:
CT PE probability Number of Clinical
of perfusion patients diagnosis
scintigraphy of PE
Massive thrombi high 4 4
intermediate 0 0
Low 1 1
Inocclusive thrombi high 1 1
intermediate 3 1
Low 6 0
No thrombus high 4 1
intermediate 2 0
Low 4 0
Conclusions:
1. Perfusion scintigraphy allows highly accurate diagnosis of  pulmonary embo-
lism,  is cheaper than CT and results in fewer side effects.
2. Results of both methods were most discordant when  CT scan showed inocclu-
sive thrombi or no thrombi above subsegmental level.
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SCINTIGRAPHIC ASSESSMENT OF MYOCARDIAL PERFUSION
IN CHILDREN AFTER ANATOMICAL CORRECTION OF TGA
Bogdan Małkowski, Zbigniew Maziarz, Wiesław Tryniszewski, Anna Dedecjus-
-Sysa, Jadwiga Moll
Dep. of Nuclear Medicine Military Medical University Łódź
Clinic of cardiology ICZMP Łódź
Anatomical correction in treatment of complete transposition of great arteries  (TGA)
is a method of choice. Because the transfer of coronary arteries to neoaorta is the
most crucial and difficult problem during this operation we investigate the long term
myocardial perfusion in this group of children.
310 children were operated between 1991 and 2000 and among them 29 (9%)
underwent MIBI SPECT at 4–9 years after the operation.
In 21 (75%) myocardial perfusion was normal but in 6 cases several defects of
perfusion occurred, whereas in 3 patients there was no perfusion in basal segment
of myocardial septum because of large path.
In the course of scintigraphic examination USG Doppler were also performed show-
ing normal results of total contractility.
Based upon long-term assessment it may be assumed that most patients after
anatomical correction of great arteries have no myocardial perfusion disorders.
However, these local perfusion defects are an indication to further observation and
coronary angiography because of possibility of gradual aggravation of myocardial
perfusion defects.
EFFICACY OF THE DIRECT MYOCARDIAL REVASCULARIZATION
PERFORMED ON THE BEATING HEART AND PERFORMED WITH THE
USE OF EXTRACORPORAL CIRCULATION - COMPARISON BY THE
MEANS OF MYOCARDIAL PERFUSION SPECT
P. Kwinecki*, R. Czepczyński, M. Jemielity*, W. Dyszkiewicz*, J. Sowiński
Dept. of Endocrinology and Metabolism, Univ. School of Med.Sciences, Poznań
* Dept. of Cardiac Surgery, Univ. School of Med.Sciences, Poznań
Introduction. In the recent years, new techniques of direct myocardial revascular-
ization: OPCAB – off pump coronary artery bypass and MIDCAB – minimal invasive
coronary artery bypass were developed. Aim of this study was to compare the effi-
cacy of these methods with that of CABG performed with the use of extracorporal
circulation.
Material and methods. 20 patients operated on the beating heart (group 1; 16
men and 4 women; aged 40 to 65 years; mean 53,0 ± 8,6 years) and 36 patients
operated in the extracorporal circulation (group 2; 33 men and 3 women; aged 34
to 69 years,  mean 52,5 ± 8,6 years). In all the patients myocardial SPECT using
99mTc-MIBI at rest and after stimulation with dipyridamole (0,56 mg/kg) was per-
formed twice: before and 4 – 7 months after revascularization.  Myocardial perfu-
sion was evaluated in 9 segments using following scale: from 1 (normal) to 5 points
(no uptake). The average score in all nine segments constituted a perfusion index
(PI). The differences of PI before and after operation, both at rest and after dipy-
ridamole were compared.
Results.  In none of the patients of group 1 a perioperational ischemia was found
by ECG or enzymatic (CK-MB) measurements. In a part of group 2 signs of tran-
sient  ischemia were found. Global evaluation of perfusion in SPECT is presented in
the table:
Group 1 Group 2 p
DPI – rest 3,68 ± 3,72 2,76 ± 2,97 ns
DPI – dipyridamole 7,95 ± 6,25 5,82 ± 5,40 ns
DPI were similar in both groups, both at rest and after dipyridamole.
Conclusion. Efficacy of the direct myocardial revascularization performed on the
beating heart is similar to that of the CABG operations performed with the use of
extracorporal circulation. The OPCAB and MIDCAM operations are less traumatizing.
CARDIOLOGY 2
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